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CHAPTER 1 
INTRODUCTION 
 
Antibiotics have been extensively used in livestock and poultry production since the 
last half century (Hamer 2002). Antibiotics are either used at therapeutic concentrations to 
treat infectious diseases or at the sub-therapeutic concentrations for prophylactic reasons to 
improve growth performance and feed efficiency (Huyghebaert et al. 2011). The antibiotics 
being used as prophylactic reasons are termed as antibiotic or antimicrobial growth promoters 
(AGPs). The use of AGPs results in development of microbial resistance against antibiotics 
and antimicrobials which are used for the treatment of human (Threlfall et al. 2000; 
Silbergeld et al. 2008) and animal diseases (Huyghebaert et al. 2011). 
The emergence of antimicrobial resistant microbes increases consumer pressure to 
withdraw AGPs from animal feed (Sou 1997) and, therefore, the European Commission (EC) 
decided to ban (1st January, 2006) the marketing and use of antibiotics as growth promoters in 
animal feed (EC Regulation No. 1831/2003). On the other hand, withdrawal of AGPs from 
animal feed results in poor growth performance, feed efficiency, high flock mortality and re-
emergence of some of the infectious diseases such as necrotic enteritis (Wierup 2001; Dibner 
and Richards 2005; Van Immerseel et al. 2006). The resulting crisis presents animal scientists 
with challenge to investigate alternatives to AGPs which not only provide similar or better 
production performance (Hume 2011) but also confer health and safety to humans. 
Understanding of the mechanistic behavior of AGPs in the gastrointestinal tract (GIT) 
is a key concept to investigate and identify alternatives to AGPs. Antibiotics, used as AGPs, 
are believed to inhibit the growth of pathogenic microbes, limit the GIT pathogenic microbial 
load and thus the incidence and severity of subclinical infections (George et al. 1982; 
Brennan et al. 2003), reduce competition for energy substrates between microbes and host 
(Snyder and Wostmann 1987), improve nutrient absorption and limit production of growth 
depressing toxic metabolites by pathogenic microbes (Feighner and Dashkevicz 1987; 
Knarreborg et al. 2004). Moreover, Niewold (2007) proposes that AGPs may also enhance 
growth performance by inhibiting production of inflammatory cytokines by microbial-
provoked immune cells. This phenomenon indicates that AGPs may modulate the microbial 
community towards less inflammation evoking microbiota (Niewold 2007). Therefore, 
microbiota and immune modulating compounds seem to be suitable candidates to replace 
AGPs. Many substances have been shown to mimic the mechanistic behavior of AGPs along 
with greater safety for human beings and animals. These substances include prebiotics, 
probiotics, phytotherapeutics, organic acids and exogenous enzymes (Hume 2011; 
Huyghebaert et al. 2011). 
Prebiotics are group of substances which are mostly oligosaccharides containing 
hexose monosaccharides like mannose, fructose, glucose and galactose (Durst 1996) with 
different degrees of polymerization (d.p.) ranging between two to twenty monosaccharides. 
Gibson et al. (2004) and Roberfroid (2007) defined prebiotics as “selectively fermentable 
carbohydrates that are resistant to gastric acidity and host hydrolytic enzymes, non-
absorbable, fermented by GIT microbiota and allow specific changes, both in the composition 
and/or activity of one or a limited number of gastrointestinal microbiota that confer benefits 
upon host well-being and health”. Prebiotics include mannan-oligosaccharides, pectic-
oligosaccharides, soybean-oligosaccharides, isomalto-oligosaccharides, xylo-
oligosaccharides, fructo-oligosaccharides, galacto-oligosaccharides, transgalactosylated 
oligosaccharides, inulin and lactulose (Morgan et al. 1992; Saito et al. 1992; Campbell et al. 
1997; Tuohy et al. 2002; Zentek et al. 2002; Olano-Martin et al. 2003; Biggs et al. 2007; 
Macfarlane et al. 2006; Jung et al. 2008; Rehman et al. 2008). 
Galacto-oligosaccharides (GOS), d.p. between two to ten, are produced by enzymatic 
hydrolysis of lactose by β-galactosidase (Prenosil et al. 1987). The GOS has been studied in 
humans (Moro et al. 2002; Boehm et al. 2005; Haarman and Knol 2005; Vulevic et al. 2008), 
pigs (Smiricky-Tjardes et al. 2003), rats (Rowland and Tanaka 1993), mice (Vos et al. 2006) 
and poultry (Biggs et al. 2007; Jung et al. 2008). These studies indicate that dietary GOS 
supplementation increases the populations of Bifidobacteria and Lactobacilli in feces or 
digesta. In addition, GOS has also been shown to enhance delayed-type hypersensitivity in 
murine influenza vaccination model (Vos et al. 2006), natural killer cells activity in humans 
(Vulevic et al. 2008) and mice (Gopalakrishnan et al. 2012), and decreases pro-inflammatory 
cytokine production in humans (Vulevic et al. 2008). However, GOS supplementation fails to 
improve the body weight, feed intake and feed conversion efficiency in poultry when 
supplemented at 30-120 g/kg of corn-soybean based feed (Jung et al. 2008). Biggs et al. 
(2008) reported similar findings in broilers after dietary trans-GOS supplementation. 
Organic acids are group of weak acids having terminal carboxylic group and contain 
between one to seven carbon atoms (maximum ten carbon atoms). Organic acids, salts of 
organic acids and their cocktails have been used for many years as feed and food 
preservatives (Jay 1992; Ricke 2003), silage preservatives (Wildgrube and Zausch 1971), 
slaughter house by-products preservatives (Pölönen et al. 1998), antimicrobial and antifungal 
agents (Brul and Coote 1999; Ricke 2003), and feed additives in poultry nutrition 
(Huyghebaert et al. 2011). Organic acids used in poultry nutrition include benzoic acid, citric 
acid, formic acid, fumaric acid, gluconic acid, lactic acid, propionic acid and their cocktails 
(Rafacz-Livingston et al. 2005a; Hernandez et al. 2006; Sacakli et al. 2006; Józefiak et al. 
2007; Liem et al. 2008; Pirgozliev et al. 2008; Józefiak et al. 2010; Goodarzi Boroojeni et al. 
2014a, b). Organic acids are thought to cross the microbial cell membrane in un-dissociated 
form (Van Immerseel et al. 2006), which dissipates the proton motive force across cell 
membranes (Russell 1992) and, therefore, can limit the growth of pathogenic microbes. 
Antimicrobial activities of organic acids are influenced by their chemical nature, animal 
species and feed buffering capacity (Thompson and Hinton 1997). In addition to the 
antimicrobial properties, organic acids may contribute some energy to the host (Jamroz et al. 
2002) and improve protein digestion by increasing intestinal enzymes production and 
activities (Partanen and Mroz 1999). These properties of organic acids can converge in 
improved growth performance of the animals. 
Benzoic acid (BA), a simple organic acid, is common in pig nutrition and has been 
shown to improve weight gain and feed efficiency (Guggenbuhl et al. 2007). Studies based on 
in vitro and in vivo trials demonstrate that BA reduces coliforms and lactic acid bacteria 
(Knarreborg et al. 2002), caecal microbiota in pigs (Biagi and Piva 2005), E. coli in weaning 
piglets (Torrallardona et al. 2007), and gram-negative bacteria in pigs (Kluge et al. 2006). 
Few studies demonstrate the effect of BA supplementation on growth performance, feed 
efficiency and GIT microbiota in poultry (Józefiak et al. 2007, 2010). Higher concentrations 
of BA (0.5-0.75%) depress the growth performance, feed efficiency and coliforms population 
in broilers (Józefiak et al. 2007). Supplementation of 0.1% BA improves growth performance 
and feed efficiency during starter periods. However, 0.2% BA supplementation depresses 
growth performance in broilers (Józefiak et al. 2010). Lactic acid bacteria concentration 
increases in ileal digesta by 0.2% BA, whereas, 0.1-0.2% BA supplementation decreases 
coliforms in ileal digesta. In addition to these effects, BA supplementation also changes the 
profile of various short chain fatty acids in different GIT segments of broilers (Józefiak et al. 
2010). 
CHAPTER 2 
REVIEW OF LITERATURE 
 
2.1. Prebiotics 
In the light of the ban on antibiotics as "growth promoters" in European Union new 
ideas for controlling gastrointestinal microbial populations (Ricke 2003) are urgently 
required. Prebiotics including mannan-oligosaccharides, pectic-oligosaccharides, soybean-
oligosaccharides, isomalto-oligosaccharides, xylo-oligosaccharides, fructo-oligosaccharides, 
galacto-oligosaccharides, transgalactosylated oligosaccharides, inulin and lactulose (Morgan 
et al. 1992; Saito et al. 1992; Campbell et al. 1997; Tuohy et al. 2002; Zentek et al. 2002; 
Olano-Martin et al. 2003; Biggs et al. 2007; Macfarlane et al. 2006; Jung et al. 2008; Rehman 
et al. 2008) have been used with variable degrees of success in different animal species 
including poultry. 
2.1.1. Growth Performance and Feed Conversion Efficiency 
Prebiotic oligosaccharides that mimic oligosaccharides of human milk were chosen by 
Vos et al. (2006) and a trial was conducted in mice using an influenza vaccination model. The 
results of the study demonstrated that body weights and feed intake remained unaffected by 
dietary supplementation of prebiotics. An experimental model was devised to evaluate the 
effect of prebiotic, probiotic and combinations on performance and faecal microbiota of 
broilers. No significant differences in body weight, feed intake and feed conversion 
efficiency (FCE) were found among different treatment groups (Jung et al. 2008). Similar 
observations were stated by researchers on inclusion of galacto-oligosaccharides (GOS) to 
poultry and pigs (Mountzouris et al. 2006; Biggs et al. 2007). The health related 
consequences of short-chain fructo-oligosaccharides (scFOS) and GOS supplementation 
were investigated in healthy adult cats by feeding them with different diet plans and it was 
found that food intake was not different among groups (Kanakupt et al. 2011). An 
experimental model was developed to observe the effects of low levels of GOS in human 
infant formula on gut microflora. Parameters like weight gain and increase in body height 
remained unchanged among groups (Ben et al. 2008). 
Three experiments were designed to investigate the effects of different types of 
oligosaccharides including inulin, oligo-fructose, mannan-oligosaccharides (MOS), scFOS 
and transgalacto-oligosaccharides on performance, nutrients digestibilities and bacterial 
populations in broilers. The 8 g/kg and 4 g/kg of oligosaccharides added corn-soybean based 
diet did not affect weight gain, feed intake and FCE in broilers (Biggs et al. 2007). 
Supplementation of FOS (3.75 g/kg) improved weight gain in broilers (Ammerman et al. 
1989), however, in another trial, the same dose of FOS supplementation to broilers did not 
significantly affect weight gain (Waldroup et al. 1993). Stanczuk et al. (2005) reported no 
effect on weight gain in turkeys fed the diets containing MOS or inulin. Contrary to these 
observations, Sims et al. (2004) stated improved gain in body weight of turkeys when the 
birds were fed MOS added diets. Pelicano et al. (2004) also reported that weight gain and 
FCE were improved by inclusion of MOS in the diet of broilers. Results from the previous 
studies and the study of Biggs et al. (2007) indicated that the impact of prebiotics 
supplementation on growth performance in poultry are not consistent. 
2.1.2. Digesta Microbial Populations 
Prebiotic oligosaccharides that show structural resemblance to human milk 
oligosaccharides were administered to mice using an influenza vaccination model. The 
GOS/FOS showed dose dependent significant increase in faecal Bifidobacteria and 
Lactobacilli compared to control group (Vos et al. 2006). Similar effects were reported in 
human infants (Boehm et al. 2003; Moro et al. 2003; Schmelzle et al. 2003; Boehm et al. 
2004). Healthy human adults were fed GOS-containing product and their faecal samples were 
analyzed to check the effects of prebiotic on wide variety of faecal microbiota. During the 
baseline periods the composition of most common microbiota at genera level included 
Bacteroides (12.2%), Fecalibacteria (7.7%), Blautia (7.4%), Ruminococci (3.7%), Roseburia 
(2.2%), Bifidobacteria (1.5%) and Dorea (1.3%). The GOS supplementation induced a 
substantial increase in phylum Actinobacteria, especially due to a significant rise in 
Bifidobacteria compared to the control subjects and a major reduction in phylum 
Bacteroidetes due to significant decline in genus Bacteroides. Increase in Firmicutes was also 
detected by GOS supplementation (Davis et al. 2011). Davis et al. (2010) stated strong 
bifidogenic shift in the bacterial population of healthy humans. Prebiotics according to 
definition are "selectively fermentable carbohydrates and have the ability to induce specific 
changes in the microbiota of gastrointestinal tract" (Roberfroid 2007). Many studies have 
evaluated the effects induced by GOS consumption on stability and diversity of human 
intestinal microbes (Tannock et al. 2004; Maukonen et al. 2008; Davis et al. 2010). The 
results, mentioned above, were collected using high throughput pyrosequencing, which 
provided in depth analysis of gut microbial population of individuals, who were consuming 
prebiotics. For the first time, pyrosequencing data indicated that changes related to GOS 
intake are limited to small number of bacterial groups. The only bacteria that showed 
consistent increase were species of Bifidobacteria which was related to decrease in genus 
Bacteroides. Thus, enrichment of Bifidobacteria by GOS occurs at the expense of diverse 
collection of bacteria, including two phyla and many species. It is, therefore, obvious that 
increase was far more specific than decrease. Although GOS showed striking selectivity 
under an in vivo environment but its fermentation by microbes under in vitro condition was 
less selective because many microbes living in the colon were able to ferment GOS for 
growth. Gibson et al. (2004) stated that substrate preferences and competitive forces present 
in the gastrointestinal milieu are either dissimilar or missing in pure culture. The outcome of 
the trial indicated that Bifidobacteria are biochemically and physiologically well adapted to 
ferment GOS and thereby out-compete intestinal microbes for GOS. Pyrosequencing 
confirmed a previous finding that the response to GOS inclusion in the diet is markedly 
related to individual variation (Davis et al. 2010). It is possible that non-responders to GOS 
lack such Bifidobacteria strains that can efficiently utilize GOS as substrate (Kneifel et al. 
2000; Makelainen et al. 2010). Individual variation can also depend upon other factors like 
gut pH or diminished growth limiting nutrients that may limit the growth of microbes even in 
the presence of suitable substrates (Martinez et al. 2010; Duncan et al. 2009). In addition to 
that host digestive enzymes probably can affect the GOS concentration that may withstand 
digestion and reach in intact form to the distal parts of large intestine. 
Jung et al. (2008) investigated effects of a prebiotic and probiotic on performance and 
faecal microbes of broilers. The GOS treatment significantly enhanced the total anaerobes, 
Bifidobacteria and Lactobacilli and in faeces and increase in bacterial count due to GOS was 
found to be dose dependent. The GOS and B. lactis treated group showed 3.4 fold increase in 
total anaerobic bacteria, 3.56 fold increase in Lactobacilli and 21 fold increase in 
Bifidobacteria in faecal samples when compared with control birds. Co-supplementation of 
GOS and Bifidobacteria resulted in increased faecal Bifidobacteria population in comparison 
to group supplemeted with Bifidobacteria only. The GOS is not extensively studied in 
animals but bifidogenic effects of GOS in humans are reported by many researchers (Alander 
et al. 2001; Malinen et al. 2002; Gopal et al. 2003). The ability of GOS to cause significant 
modification in the intestinal microbial community has been reported in many previous 
animal studies. Dietary inclusion of GOS in pigs resulted in significant increased faecal 
concentrations of Bifidobacteria and Lactobacilli (Smiricky-Tjardes et al. 2003). It was 
observed that GOS-containing diets caused significant rise in total anaerobes, Lactobacilli 
and Bifidobacteria numbers with concomitant fall in Enterobacteria in rats (Rowland and 
Tanaka 1993). Significant elevation in human intestinal Lactobacilli and Bifidobacteria along 
with a fall in Bacteroides and Candida numbers was noted by Ito et al. (1990). A rise in total 
bifidobacterial count in humans taking GOS-syrup and B. lactis Bb-12 has also been 
observed (Alander et al. 2001). 
The scFOS and GOS were fed to healthy adult cats and their effects were 
investigated. Faecal Bifidobacteria increased in groups fed scFOS, GOS or scFOS + GOS 
compared to control group and highest faecal count of Bifidobacteria was found in group fed 
scFOS + GOS containing diet. Faecal levels of Lactobacilli, E. coli and C. perfringens 
remained unchanged among treatment groups (Kanakupt et al. 2011). It was stated by Terada 
et al. (1993) that 175 mg/day lacto-sucrose supplementation to cats resulted in higher faecal 
Bifidobacteria, Lactobacilli and lower Clostridia. When cats were fed diet containing 4% 
oligofructose and a diet containing cellulose, the former diet elevated Bifidobacteria count 
(Barry et al. 2010). When dogs were fed diet having FOS + MOS (4 g + 2 g) or 1.5% scFOS 
(Swanson et al. 2002b; Middelbos et al. 2007), faecal numbers of Bifidobacteria and 
Lactobacilli were improved. Moreover, inclusion of scFOS or inulin at low levels (0.2% and 
0.4%) has no effect on gastrointestinal microbes of canine (Barry et al. 2009). 
An infant milk formula containing 0.6% scGOS and lcFOS, in a ratio of 9:1, was fed 
to healthy human infants and effects on immunity and intestinal microbial population were 
checked. At the end of trial period, the scGOS/lcFOS group presented a higher percentage of 
Bifidobacteria and a lower percentage of Clostridia compared with control subjects 
(Scholtens et al. 2008). Bifidogenic effects of scGOS/lcFOS mixtures have been reported by 
many researchers (Boehm et al. 2002; Moro et al. 2002; Schmelzle et al. 2003; Knol et al. 
2005; Scholtens et al. 2006). During the trial of Scholtens et al. (2008), all groups showed 
that the microbial population was dominated by Bifidobacteria but surprisingly the 
Bifidobacteria percentages seemed to be low in breast fed group and similar findings were 
reported by Bakker-Zierikzee et al. (2005). In a recent experiment conducted by Penders et 
al. (2007), the Bifidobacteria count was same in breast fed and formula fed infants. Although 
the findings of the trial of Scholtens et al. (2008) were unexpected, that may point towards 
regional differences in breast milk composition or in gut microbial composition. Comparative 
studies in humans have pointed out that different countries have different percentages of 
Bifidobacteria (Mueller et al. 2006). 
Low levels of GOS were fed to human infants in infant formula milk and their effects 
on intestinal microflora were observed. The group receiving GOS contained infant milk 
formula and breast-fed showed significant rise in Bifidobacteria and Lactobacilli when 
compared with group fed only infant milk formula. The E. coli count remained unchanged 
among all the treatment groups (Ben et al. 2008). The intestinal microbial community of 
breast fed infants mostly contains Lactobacilli and Bifidobacteria (Fanaro et al. 2003; 
Harmsen et al. 2000) which is different in standard infant formula fed infants (Rubaltelli et al. 
1998). Inclusion of probiotics inclusion in infant milk formula influenced infants' microbes 
versus breast fed infants microbial community (Langhendries et al. 1995; Parracho et al. 
2007). Prebiotics fermentation leads to formation of volatile fatty acids and lactic acid which 
can limit the growth of acid-sensitive pathogens (Bovee-Oudenhoven et al. 1997). Colonic 
epithelial cells prefer volatile fatty acids as an energy source and colonocyte proliferation 
may also be stimulated by volatile fatty acids. It is proposed that volatile fatty acids also 
increase the glucose uptake from small intestine (Chen and Walker 2005) by increasing the 
expression of glucose transporters (Reimer et al. 1997). These organic acids can also injure 
gut mucosa and impair barrier function which is pointed by enhanced cytotoxicity of faecal 
water and faecal mucin excretion (Ten Bruggencate et al. 2003). Probably the fermentation 
rate is an important factor for this detrimental effect. As in the case of resistant starch, slow 
fermentation did not enhance faecal mucin and luminal cytotoxicity. Therefore, 
administration of a low level of rapidly fermentable carbohydrates can prevent intestinal 
irritation (Bovee-Oudenhoven et al. 2003). In a rat trial, Ten Bruggencate et al. (2003) 
reported that FOS (6%) elevated Bifidobacteria count, however, low level of FOS (3%) 
caused a significant rise in Enterobacteria. Elevated Enterobacteria along with compromised 
intestinal barrier can enhance the danger of bacterial translocation (Ten Bruggencate et al. 
2003). Oligosaccharide supplement, in different concentrations (0.4 and 0.8 g/dL), caused 
significant rise in concentration of Lactobacilli and Bifidobacteria in full term infants (Moro 
et al. 2002). It was shown by Boehm et al. (2002) that GOS/FOS mixture showed bifidogenic 
effect with no change in Enterobacteria and Lactobacilli counts. Smad3-deficient mice were 
challenged with Helicobacter hepaticus and supplemented with GOS to study effects on 
colitis development. The GOS supplementation showed 1.5 fold increase in faecal 
Bifidobacteria but faecal Lactobacilli remained unchanged between GOS group and control 
group (Gopalakrishnan et al. 2012). 
Three experiments were designed by Biggs et al. (2007) to investigate the effects of 
different types of oligosaccharides on performance, nutrient digestibilities and bacterial 
populations in broilers. Corn-soybean based diet having 4 g/kg of oligosaccharides indicated 
no impact on caecal E. coli, Lactobacilli, Bifidobacteria and C. perfringens counts but when 
birds were fed dextrose-isolated soy protein diet having scFOS or MOS at the rate of 4 g/kg, 
caecal population of C. perfringens was declined. Manipulating the composition and growth 
of gut microbial population is of utmost value to improve host health. Intestinal bacteria 
compete with the host for nutrients and elicit an immune response which reduces appetite and 
increases muscle catabolism (Bedford 2000). Therefore, it is imperative to encourage growth 
of beneficial microbes that have the ability to provide nutrients to host and can prevent 
growth of harmful microbes. Bifidobacteria and Lactobacilli have been shown to improve 
health of the host and limit the growth of pathogenic microbes (Fuller 1977; Gibson and 
Roberfroid 1995). Moreover, it was observed that dietary supplementation of 6% 
oligofructose or scFOS to rats improved caecal population of Bifidobacteria (Campbell et al. 
1997). In many human studies, dose range from 5 to 20 g/day for oligofructose, increased 
Bifidobacteria number (Niness 1999). Caecal Lactobacilli showed rise in number with 
decline in E. coli concentration when Xu et al. (2003) fed broiler chickens with FOS in corn-
soybean based diet. In the first 2 experiments, Biggs et al. (2007) used corn-soybean based 
diets to observe the effects of different oligosaccharides in basal diet. Corn-soybean based 
diet having 4 g/kg of oligosaccharides of any type had no effect on caecal microbial 
community. Absence of response in caecal microbes probably has resulted due to high 
concentration of indigestible oligosaccharides in soybean meal. The third trial was planned to 
determine the effect of each oligosaccharide on caecal microbes in dextrose-isolated soy-
protein based diet. The scFOS and MOS containing dextrose-isolated soy-protein based feed 
lowered the concentrations caecal Clostridia, indicating that this feed might be more sensitive 
than corn-soybean based feed for evaluating the consequences of oligosaccharides on 
intestinal microbes. 
A second generation prebiotic β-galacto-oligosaccharides mixture (β-GOS) was 
tested under in vitro conditions using three stage continuous culture system. Bifidobacteria 
showed higher counts in the presence of β-GOS than in the presence of inulin or GOS 
(Tzortzis et al. 2005). Piglets were given second generation prebiotic β-GOS along with other 
prebiotics in feed to evaluate their effects on intestinal microflora. Piglets fed with β-GOS 
added commercial diet showed significantly higher levels of Bifidobacteria as compared with 
the piglets fed with inulin added commercial diet or control commercial diet (Tzortzis et al. 
2005). A trial was designed and healthy adult humans were given prebiotics (control diet 
maltodextrin, β-GOS and GOS) to ponder upon their effects on human gut flora. 
Bifidobacteria population was significantly higher in β-GOS treated subjects compared with 
GOS or placebo subjects. The relationship between β-GOS and Bifidobacteria numeral 
increase was dose dependent (Depeint et al. 2008). Healthy elderly humans were chosen to 
evaluate the effects of β-GOS on intestinal microbiota and immunity. The β-GOS supplement 
significantly improved Bifidobacteria concentration after five and ten weeks of treatment in 
comparison with baseline and control (Vulevic et al. 2008). Irritable bowel syndrome (IBS) 
patients were chosen to supplement with β-GOS (1.33 and 2.75 g/day) and investigate their 
effects on these patients. Both doses of β-GOS resulted in significant elevation of 
Bifidobacteria population accompanied by decline in IBS severity (Silk et al. 2009). 
2.1.3. Immunity 
Prebiotic oligosaccharides, having similar characteristics to those of human milk 
oligosaccharides, were chosen in a study trial to observe their immuno-modulatory 
properties. Influenza vaccination model was used in mice and it was observed by Vos et al. 
(2006) that GOS/FOS induced dose dependent elevation in delayed type hypersensitivity 
(DTH) responses. Changes related to splenocyte proliferation and vaccine-specific antibody 
concentrations were insignificant. The study indicated that GOS/FOS mixture elevated 
systemic adaptive immune response. Supplementation of GOS/FOS mixture improved Th1-
dependent immunity at low doses which was shown by enhanced DTH response after 
vaccination. Though the level of immune-modulatory effect regarding GOS/FOS at 1 to 2.5% 
doses were different between two experiments, the stimulatory effects of the GOS/FOS 
mixture on the DTH response after vaccination remained consistent. This effect seems to be 
GOS/FOS specific as other supplements failed to modulate the DTH response. The GOS/FOS 
mixture did not show any effect on vaccine induced splenocyte proliferation, indicating that 
elevation in the general activation status of splenic vaccine-specific T-cells is not the cause of 
enhanced DTH response. Immuno-modulatory effects of prebiotics are being reported by 
others as well but the main focus of these studies was the mucosal immune system. In 
previous studies on animals, prebiotics have been shown to affect Payer's patch (PP) 
lymphocyte populations and cytokine production (Manhart et al. 2003; Roller et al. 2004), 
enhanced PP and intestinal IgA production (Nakamura et al. 2004). Systemic effects 
regarding total IgE serum concentrations (Nagura et al. 2002), natural killer cell activity and 
phagocytic activity (Kelly-Quagliana et al. 2003), tumor occurrence (Pierre et al. 1997; Taper 
et al. 1998; Pierre et al. 1999; Reddy et al. 1999; Buddington et al. 2002) and murine 
mortality rates after systemic infections with Listeria monocytogenes and Salmonella 
typhymurium (Buddington et al. 2002) have also been reported. But these studies did not 
show direct evidence for modulation of systemic adaptive immune responses. It was also 
reported that specific probiotics enhanced DTH responses in mice and rats (de Waard et al. 
2003). Therefore, may be GOS/FOS mixture in diet caused similar effects on DTH responses 
and modulated gut microbial population. There is a possibility that GOS/FOS and not 
FOS/inulin stimulated certain bacterial strains and enhanced DTH responses. 
Oligosaccharides may also directly effects the immune system as a small amount of FOS is 
being absorbed and secreted in urine (Molis et al. 1996). Intra-peritoneal administration of 
short chain oligosaccharides affected airway eosinophilia in rats (Sonoyama et al. 2005). 
Theoretically, increase in systemic Th1-dependent adaptive immune response will cause 
better immune response against infections. 
When scFOS and GOS were fed to healthy adult cats, white blood cells, neutrophils 
and lymphocytes levels remained unaffected (Kanakupt et al. 2011). Earlier studies, 
involving scFOS, inulin or yeast cell wall showed incoherent consequences on immune 
parameters which depend upon the level and nature of prebiotics (Swanson et al. 2002a,b; 
Middelbos et al. 2007; Barry et al. 2009). Higher levels of prebiotics administration seem to 
be necessary to modulate immune parameters (Middelbos et al. 2007; Barry et al. 2009). 
Healthy human infants were subjected to a study trial to observe the effects of an infant milk 
formula containing 0.6% scGOS and lcFOS, in a ratio of 9:1, on immunity and intestinal 
microbial population. Group fed with scGOS/lcFOS containing infant milk formula showed 
elevation in slgA concentration compared with slgA concentration in control group. High 
concentration of faecal slgA due to scGOS/lcFOS containing infant milk formula can be 
indication of improved mucosal immunity (Scholtens et al. 2008). Similar results were also 
presented by Bakker-Zierikzee et al. (2006) during a trial. Besides providing sIgA, breast 
milk contains many factors such like sIgA-stimulating cytokines which modulate the immune 
system of infants (Hanson et al. 2003; Field 2005). When Kuitunen and Savilahti (1995) 
compared faecal sIgA concentration in term and preterm infants that received breast milk or 
formula milk, sIgA levels were higher in breast fed infants. Probiotics also elevate faecal 
sIgA concentration (Fukushima et al. 1998). When Fukushima et al. (1998) fed the infants 
with formula milk containing Bifidobacterium lactis Bb-12, a rise in level of faecal sIgA was 
observed. An infant formula fermented with Bifidobacterium breve strain C50 and 
Streptococcus thermophiles did not elevate levels of total faecal sIgA in healthy infants 
(Mullie et al. 2004). The main function of faecal sIgA is to cause agglutination of 
microorganisms as well as prevention of pathogens attachment to gut mucosa (Mazanec et al. 
1993; Bouvet and Fischetti 1999; Walker 2000; Hanson et al. 2003; Van de Perre 2003). 
Another important task of sIgA is to maintain intestinal microbial homeostasis. Animal trials 
have pointed out that in the absence of normal sIgA, anaerobic bacteria show substantial 
increase levels in the small intestine of mice and when sIgA production returned to normal 
value, the regular composition of intestinal microbiota could also be seen (Suzuki et al. 
2004). In this way composition of intestinal microbes regulates production of sIgA and in 
turn, sIgA regulates the gut microbial ecology to limit overstimulation of immune system. 
Gopalakrishnan et al. (2012) supplemented the Smad3-deficient Helicobacter 
hepaticus challenged mice with GOS to study its effect on colitis development and immune 
system. The GOS treatment significantly reduced colitis with concomitant rise in NK cells 
percentage in spleen and mesenteric lymph nodes (MsLN) three days post-infection. The 
GOS increased NK expression of CCR9 at zero day pre-infection in blood, spleen and MsLN 
accompanied by stimulation of colonic IL-15 at three days post-infection. The role played by 
commensal microbes of intestine is of utmost importance in regulating the innate and 
adaptive immune system (Roberfroid et al. 2010). A change in microbial composition that 
includes lower counts of Bifidobacteria and higher counts of Bacteroides and Enterobacteria 
was observed in people with IBD (Favier et al. 1997; Seksik et al. 2003). Prebiotic intake had 
impact on the composition of the microbial population and enhanced useful bacterial count 
like Lactobacilli and Bifidobacteria (Roberfroid et al. 2010). It is considered that these 
bacteria provide many benefits through different processes like improving immune functions 
and gut barrier and reducing intestinal inflammation, and/or decreasing pathogens 
colonization (Ewaschuk and Dieleman 2006; Yan and Polk 2010). During the study 
performed by Gopalakrishnan et al. (2012), feeding GOS caused significant reduction of 
colitis which was shown by limited penetration of inflammatory cells in caecum and colon 
and goblet cells depletion. Earlier trials have shown that probiotics and prebiotics treatments 
augment function of NK cells and production of IL-15 (Bassonga et al. 2001; Gill et al. 2001; 
Gori et al. 2011). In the study of Gopalakrishnan et al. (2012), a significant and higher 
percentage of NK cells in the MsLN both at baseline and at 3 day post-infection was noted in 
GOS treated mice. This was in agreement with a report that GOS treatment increased 
chemokine receptors expression that is important for lymphocyte homing to intestinal tract 
(Nishimura et al. 2009; Hornung et al. 2011). After GOS inclusion, Gopalakrishnan et al. 
(2012) noted a decline in the percentage of NK cells in the MsLN expressing CD62L. There 
was an interesting observation i.e., a rise in NK cells within the MsLN of mice treated with 
GOS and this process requires CD62L. It can be associated to hypothesis that in vivo, NK 
cells can re-express CD62L (Juelke et al. 2010). In agreement with the changes noted in NK 
cell count and receptor expression, GOS caused a significant enhancement in colonic 
expression of IL-15. In intestine, IL-15 is an imperative mediator of immune response that 
includes proliferation of T-cells, antibodies production, differentiation and maturation of NK 
cells (Waldmann and Tagaya 1999; Zhang et al. 2008). During IBD, concentration of IL-15 is 
increased (Sakai et al. 1998; Liu et al. 2000), but IL-15 depletion disrupts innate response to 
pathogens that is linked to decreased NK cells activities and compromised resistance to 
colonization (Umemura et al. 2001; Ashkar et al. 2009; Inoue et al. 2010). 
Healthy elderly humans were chosen to judge the effects of second generation 
prebiotic β-GOS on intestinal microbiota and immunity. There was significant rise in activity 
of phagocytic and NK cells after β-GOS treatment. Moreover, there was significant decline in 
pro-inflammatory cytokines with significant rise in anti-inflammatory cytokines (Vulevic et 
al. 2008). Immuno-modulatory properties of prebiotics were tested by in vitro use of β-GOS 
on human colonic NCM 460 cells. The β-GOS presence significantly reduced TNF-α-induced 
IL-8 and MIP-3α secretions as compared to those stimulated by TNF-α alone, thus, indicating 
that inclusion of β-GOS supplement in diet may reduce inflammatory response of intestinal 
innate immune system (Dubert-Ferrandon et al. 2008). 
2.2. Organic Acids 
 Organic acids represent a further possibility for controlling gastrointestinal microbial 
populations (Ricke 2003). Organic acids or their salts have already been supplemented as 
dietary components for domestic animal including poultry (Mroz et al. 2000; Pölönen et al. 
2000; Ricke 2003; Chaveerach et al. 2004; Kluge et al. 2006). 
2.2.1. Growth Performance and Feed Conversion Efficiency  
Organic acids were first used in animal diet as anti-fungal agents (Paster 1979; Dixon 
and Hamilton 1981). In recent years scientists have examined many organic acids and 
reported that gluconic acid or citric acid supplementation to broilers improve phosphorus 
consumption (Boling et al. 2000; Angel et al. 2001; Boling Frankenbach et al. 2001; 
Metwally 2001; Snow et al. 2004; Rafacz-Livingston et al. 2005a, b). In order to examine 
effects of different organic acids including citric acid, gluconic acid, fumaric acid and malic 
acid; on growth performance, nutrient digestibility and caecal populations in male chicks, 
four experiments were carried out by Biggs and Parsons (2008). In the first experiment all 
organic acids decreased the growth performance of chicks compared with the control birds. 
Chicks supplemented with 6% gluconic acid showed least weight gain with respect to control 
chicks. The citric acid and two levels of gluconic acid (4%, 2% and 4%, respectively) 
administration in diet indicated intermediate weight gain. Parameters like feed intake and 
gain gave no significant difference. The antibiotic, bacitracin, did not affect feed intake and 
body weights gain during the whole experiment. During the second experiment, gluconic acid 
(1, 2 and 3%) containing feeds decreased weight gain and FCE. Diets had no effect on feed 
intake. During time period of forth experiment all three doses of fumeric acid (1.5, 3 and 
4.5%) indicated no effect on overall performance or FCE. The 4% malic acid depressed 
weight gain and feed intake during the whole period of trial. Feed conversion efficiency 
remained non significant during whole course of trial for any dietary supplements (Biggs and 
Parsons 2008). The lack of improvement in growth performance may be due to difference in 
phosphorus quantity in feed. In abovementioned researches, phosphorus deficient diets were 
to observe effects on phosphorus utilization. As a result, reports of improved growth signs 
were may be due to better phosphorus utilization. But the diets used by Biggs and Parsons 
(2008) were rich in phosphorus. Negative palatability effects may not be the factor for growth 
depression by organic acids. 
Czerwiński et al. (2010) used dietary pea, organic acids and probiotic to examine the 
changes in performance and intestinal microflora of broilers. No difference was observed in 
weights among different dietary treatments. However, interaction was observed, for liver 
weights, between acid and probiotic supplementations. Organic acid supplementation 
increased liver weights in birds given a diet without probiotic but at the same time decreased 
liver weights in birds were observed that were given probiotic supplemented diets. Organic 
acid blend had no effect on bird performance. In an another experiment conducted by 
Józefiak et al. (2007), benzoic acid was administered in the diet of broiler chickens and it was 
observed that although growth performance of control birds and 2.5 g/kg feed supplemented 
benzoic acid birds was same, the inclusion of 5.0 and 7.5 g/kg feed of benzoic acid lessened 
the growth and increased the FCE. When broilers are fed vegetable diets based on soyabean 
meal, glycine is the limiting amino acid in the early period of life (Corzo et al. 2004). Dietary 
benzoic acid may thus decrease glycine availability and may lead to reduced growth rate in 
chickens. A growth performance trial was conducted by Józefiak et al. (2010) to examine 
benzoic acid impact at different doses on cockerels. Control diet and 0.1% benzoic acid diet 
had similar effect with respect to weight gain. The 0.2% benzoic acid containing diet 
depressed broiler weight gain, whereas, 0.1% benzoic acid group showed lowest FCE. In 
earlier studies, Józefiak et al. (2007) reported that when benzoic acid was fed at 
concentrations 0.25-0.75%, a similar growth depressing effect was seen. In piglets, a much 
higher concentration of benzoic acid (1%) was used and it was observed that benzoic acid fed 
piglets had higher feed intake compared with the control piglets (Kluge et al. 2006). Contrary 
to this, 1% benzoic acid administration to barrows showed no improvement with respect to 
weight gain and FCE (Buhler et al. 2006). The mechanism of growth reduction in broilers, 
when fed at higher than 0.1% benzoic acid concentration, is unclear. However, it can be 
linked with involvement of ornithine during metabolic conjugation with benzoic acid as 
domestic poultry is shown to excrete benzoic acid and aromatic acids in conjugation with 
ornithine (Williams 1959; Nesheim and Garlich 1963). It is, therefore, hypothesized that 
dietary supplementation of benzoic acid may lead to arginine deficiency which is the only 
source for ornithine in birds (Chu and Nesheim 1979). During trial, FCE was improved 
following benzoic acid inclusion in starter period, however, 0.2% benzoic acid 
supplementation impaired FCE and it can be related with arginine deficiency. Improved FCE 
during early growth phase in broilers can be attributed to bacteriostatic activity of benzoic 
acid and thus limiting competition between host and microflora for available nutrients. 
Bosund (1962) reported that benzoic acid has antimicrobial characteristics which are due to 
inhibition of microbial enzymes especially α-ketoglutaric acid dehydrogenase and succinic 
acid dehydrogenase. 
A performance trial was designed by Kluge et al. (2006) during which benzoic acid 
was fed to piglets and certain parameters like performance, nitrogen balance, nutrients 
digestibility and gastro-intestinal microflora were evaluated. Benzoic acid inclusion showed 
dose dependent improvement in feed consumption, weight gain as well as FCE. The group 
supplemented with benzoic acid (10 g/kg) outperformed the non supplemented group in feed 
intake, weight gain as well as FCE. Lactating sows were tested for the effect of different 
doses of benzoic acid. Only 2% benzoic acid concentration decreased feed intake (0.9 kg/d) 
compared to control group but the effect was statistically non significant (Kluge et al. 2010). 
In another trial, calcium benzoate (2.4%) supplementation did not show any effect on feed 
intake in growing pigs (Mroz et al. 2000). It indicated that sows might be sensitive to benzoic 
acid compared with growing pigs in relation to feed consumption. 
2.2.2. Digesta Short Chain Fatty Acids 
In broilers, caecum is the site for fermentation of different fermentable compounds 
(Józefiak et al. 2007) that results in production of short chain fatty acids (SCFAs). Moreover, 
it is also reported that small quantities of volatile fatty acids and lactic acid are produced in 
stomach of pigs (Winkenwerder 1999; Kulla 2001). In an experiment conducted on broilers, 
organic acid blend lowered acetate level in ileum and butyrate concentration in caecum 
(Czerwiński et al. 2010). During an experimental study, when piglets were fed diet containing 
benzoic acid, the concentration of acetic acid showed a significant decline in duodenal 
contents of piglets as compared to duodenal digesta of control piglets (Kluge et al. 2006). 
Changes in intestinal microbial count gave rise to alterations in synthesis of lactic acid as 
well as volatile fatty acids. The literature demonstrated that benzoic acid significantly 
decreased the acetic acid level in duodenum that may be related with a great decrease in 
concentration of gram negative bacteria of Acetobacteraceae and Enterobacteriaceae, which 
are responsible for acetic acid production (Franklin et al. 2002). Other trials, conducted on 
pigs, did not report any decline in small intestinal acetic acid concentrations following 
organic acid supplementation (Eidelsburger et al. 1992; Roth et al. 1992). 
In growth trial on broilers, Józefiak et al. (2010) examined benzoic acid impact at 
different doses. Benzoic acid supplementation had impact on SCFAs concentration on 
individual basis in the contents of different gastrointestinal segments. Total SCFAs levels 
were higher in caecum after supplementation of benzoic acid. However, lactic acid 
concentration remained unchanged in all gastrointestinal segments. In the crop, the acetic 
acid level became low due to 0.1% benzoic acid supplement while its level rose following 
0.2% benzoic acid supplement compared to control. No effects in terms of SCFAs 
concentrations were observed in the gizzard. In the ileum, 0.2% benzoic acid 
supplementation resulted in lower formic acid and butyric acid, and higher acetic acid. In 
caeca, increased concentrations of acetic acid and butyric acid, and decreased concentrations 
of propionic acid were observed after benzoic acid administration. Formic acid was higher in 
the 0.2% benzoic acid group and lower in the 0.1% benzoic acid group when put in 
comparison with control group. Rectal contents showed decrease in formic, acetic, propionic, 
iso-butyric, iso-valeric and valeric acid levels after benzoic acid inclusion. The effect of 
benzoic acid on SCFAs concentration in the lower GIT indicates that some of benzoic acid 
reached caeca and colon and changed the microbial profile. In caeca, coliforms were 
increased but lactic acid bacteria were reduced. High acetic acid concentration confirmed 
changes in Acetobacteraceae and Enterobacteriaceae number (Kluge at al. 2006). The 
findings are opposite to findings in piglets, where benzoic acid depressed the production of 
duodenal acetic acid. 
2.2.3. Digesta Microbial Populations 
Organic acids are added in the feed of broilers to promote growth of beneficial 
intestinal microbes, which ultimately leads to pathogen inhibition by several mechanisms i.e., 
competition for nutrients, competition for receptors, immune-modulation, production of 
antimicrobial compounds and SCFAs (Patterson and Burkholder 2003; Ricke 2003; Van 
Immerseel et al. 2006). While conducting experiments on broiler chickens to evaluate the 
effects of several organic acids, Biggs and Parsons (2008) observed that citric acid inclusion 
lowered Bifidobacteria population. Except for 2% gluconic acid, which reduced 
Bifidobacteria concentration, no effect was induced by three gluconic acid diets on 
Bifidobacteria and Lactobacilli, E. coli and C. perfringens. In third experiment 4% gluconic 
acid in dextrose-casein diet did not affecte caecal microbes, whereas, 4% gluconic acid in 
dextrose-isolated soy protein diet decreased caecal Lactobacilli, E. coli and C. perfringens 
without affecting Bifidobacteria count (Biggs and Parsons 2008). Gluconic acid and citric 
acid when given in corn soybean meal diet had very little effect on microbes in caeca. These 
results are contrary to those reported in humans (Asano et al. 1994) after gluconic acid 
supplementation. Low grade response to gluconic acid added corn soybean meal diet can be 
attributed to high levels of indigestible oligosaccharides in meal. As reported by Coon et al. 
(1990) soybean meal consists of approximately 6% raffinose and stachyose that affects 
microbiota in human colon by increasing and decreasing the populations of Bifidobacteria 
and C. perfringens, respectively (Hayakawa et al. 1990). Therefore, one possibility is that 
high concentrations of indigestible soybean oligosaccharides that are already present in 
soybean meal diet could have masked the effects of gluconic acid on caecal microbes. During 
a third experiment, dextrose-casein and dextrose-isolated soy protein diets were used after 
inclusion of gluconic acid and several significant effects were observed in birds. Results 
demonstrate that gluconic acid affects caecal microbes which are more sensitive to 
semipurified dextrose-isolated soy protein diet than corn soybean meal diet. A trial, used to 
examine effects of organic acid blend along with dietary peas and probiotic on performance 
and gut microbiota profile, showed that total bacterial count in caecum was not significantly 
altered by any supplements. Inclusion of organic acid blend elevated Lactobacilli and 
Enterococci numbers (Czerwiński et al. 2010). Józefiak et al. (2007) supplemented benzoic 
acid to broilers and reported that lactic acid bacteria in caecum was more abundant in 7.5 
g/kg feed benzoic acid supplemented group. Coliform bacteria seemed to decrease in crop 
and ileal contents with rise in benzoic acid dose but the difference was significant only in 7.5 
g/kg feed benzoic acid group compared to other supplemental groups. There was no effect of 
increased benzoic acid dose on caecal concentration of coliforms. Józefiak et al. (2010) 
examined benzoic acid impact at different doses on cockerels. Lactic acid bacteria population 
in crop did not show any significant difference. Lactic acid bacteria were highest in ileum of 
0.2% benzoic acid supplemented group and lowest in caeca of 0.1% benzoic acid 
supplemented group. Coliforms showed dose dependent decrease in ileal contents, whereas, 
caecal coliforms showed no significant difference. 
During a balance study, performed by Kluge et al. (2006), impact of different 
concentrations of benzoic acid was examined. Benzoic acid supplements lowered the count of 
bacteria in digesta. Stomach showed decline in total aerobes, total anaerobes, lactic acid as 
well as gram negative bacteria. Likewise, benzoic acid decreased gram negative bacteria of 
the duodenum in a dose dependent manner and total aerobes in the ileum without affecting 
concentrations of total aerobes, total anaerobes, lactic acid as well as gram negative bacteria 
in jejunum. Benzoic acid, a weak organic acid, has antimicrobial properties on a large part 
due to its suppressive effects on a number of microbial enzymes, especially α-ketoglutaric 
acid dehydrogenase and succinic acid dehydrogenase (Bosund 1962). Growth inhibitory 
activity of benzoic acid is observed in particular for yeasts, whereas, weak effects are 
reported for bacteria (Uraih and Chipley 1976). Therefore, owing to its antimicrobial activity, 
benzoic acid caused reduction in bacterial count in gastrointestinal tract. Furthermore, one 
fact should be taken into account i.e., the basal feed used in the trial had 30-40% more 
amount of zinc and copper than required by piglets. Trials have shown that a slight excess in 
zinc and copper than the required level can show synergism with organic acids, leading to 
improved antimicrobial potency of organic acids (Smith et al. 1997; Windisch et al. 2001). 
Synergism between benzoic acid and excess amount of zinc and copper can also account for 
decline in gastrointestinal microbial counts. The study conducted by Kluge et al. (2006) 
showed that benzoic acid depressed bacterial counts in ileum. Similar results have also been 
reported by Hebeler et al. (2000) when piglets were administered with blend of potassium 
diformate and formic acid in diet. 
 STATEMENT OF PROBLEM 
The use of antibiotic or antimicrobial growth promoters (AGPs), in animal feed, 
results in development of microbial resistance against antibiotics and antimicrobials which 
are used for the treatment of human and animal diseases. The literature review illustrates that 
prebiotics and organic acids can be safe potential candidates to replace AGPs in poultry 
nutrition. Therefore, experiments were designed to evaluate the potential of usage of β-
galacto-oligosaccharides (β-GOS), a prebiotic, and benzoic acid (BA), an organic acid, on 
growth performance and gastrointestinal tract (GIT) microbiota in broilers. Organic acids are 
rapidly absorbed from the GIT leaving low concentrations in gut to produce their effects. 
Therefore, free and slow releasing forms of BA were compared in the experiment. 
OBJECTIVES 
1. to evaluate three different dietary concentrations of β-GOS (0.1%, 0.2% and 0.5%) on 
growth performance, zootechnical parameters, humoral immunity, cell mediated immunity, 
cecal microbes and serum biochemistry in broilers. 
2. to evaluate two different BA types i.e., 0.096% free BA (FBA) and 0.20% slow releasing 
BA (SBA) on growth performance, microbial metabolites, microbial populations and 
molecular microbial ecology in broilers. 
REFERENCES 
Alander M, Mättö J, Kneifel W, Johansson M, Kögler B, Crittenden R, Mattila-Sandholm T, 
Saarela M. 2001. Effect of galacto-oligosaccharide supplementation on human faecal 
microflora and on survival and persistence of Bifidobacterium lactis Bb-12 in the 
gastrointestinal tract. Int Dairy J. 11: 817-825. 
Ammerman E, Quarles C, Twining Jr PV. 1989. Evaluation of fructooligosaccharides on 
performance and carcass yield of male broilers. Poult Sci. 68: 167. 
Angel R, Applegate TJ, Christman M, Dhandu AS. 2001. Non-phytate phosphorus sparing 
effect of phytase and citric acid when fed to poults. Poult Sci. 80: 134. 
Asano T, Yuasa K, Kunugita K, Teraji T, Mitsuoka T. 1994. Effects of gluconic acid on 
human faecal bacteria. Microb Ecol Health Dis. 7: 247-256. 
Ashkar AA, Reid S, Verdu EF, Zhang K, Coombes BK. 2009. Interleukin-15 and NK1.1+ 
cells provide innate protection against acute Salmonella enteric serovar Typhimurium 
infection in the gut and in systemic tissues. Infect Immun. 77: 214-222. 
Bakker-Zierikzee AM, Alles MS, Knol J, Kok FJ, Tolboom JJ, Bindels JG. 2005. Effects of 
infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable 
Bifidobacterium animalis on the intestinal microflora during the first 4 months of life. 
Br J Nutr. 94: 783-790. 
Bakker-Zierikzee AM, Tol EA, Kroes H, Alles MS, Kok FJ, Bindels JG. 2006. Faecal SIgA 
secretion in infants fed on pre- or probiotic infant formula. Pediatr Allergy Immunol. 
17: 134-140. 
Barry KA, Hernot DC, Middelbos IS, Francis C, Dunsford B, Swanson KS, Fahey Jr GC. 
2009. Low-level fructan supplementation of dogs enhances nutrient digestion and 
modifies stool metabolite concentrations, but does not alter fecal microbiota 
populations. J Anim Sci. 87: 3244-3252. 
Barry KA, Wojcicki BJ, Middelbos IS, Vester BM, Swanson KS, Fahey Jr GC. 2010. Dietary 
cellulose, fructooligosaccharides, and pectin modify fecal protein catabolites and 
microbial populations in adult cats. J Anim Sci. 88: 2978-2987. 
Bassonga E, Forest V, Pierre F, Bornet F, Perrin P, Meflah K, Menanteau J. 2001. Cytokine 
mRNA expression in mouse colon: IL-15 mRNA is overexpressed and is highly 
sensitive to a fibre-like dietary component (short-chain fructo-oligosaccharides) in an 
Apc gene manner. Cytokine. 14: 243-246. 
Bedford M. 2000. Removal of antibiotic growth promoters from poultry diets: Implications 
and strategies to minimize subsequent problems. World’s Poult Sci J. 56: 347-365. 
Ben XM, Li J, Feng ZT, Shi SY, Lu YD, Chen R, Zhou XY. 2008. Low level of galacto-
oligosaccharide in infant formula stimulates growth of intestinal Bifidobacteria and 
Lactobacilli. World J Gastroenterol. 14: 6564-6568. 
Biagi G, Piva A. 2005. Modulation of swine cecal microflora by some organic acids. In: 
Plitzner Ch, Wetscherek-Seipelt D, Schedle K, Kraft M, and Windisch WM. 4. 
BOKU Symposium Tierernährung. Wien, Austria, 182-185. 
Biggs P, Parsons CM, Fahey GC. 2007. The effects of several oligosaccharides on growth 
performance, nutrient digestibilities, and cecal microbial populations in young chicks. 
Poult Sci. 86: 2327–2336. 
Biggs P, Parsons CM. 2008. The effects of several organic acids on growth performance, 
nutrient digestibilities, and cecal microbial populations in young chicks. Poult Sci. 87: 
2581-2589. 
Boehm G, Fanaro S, Jelinek J, Stahl B, Marini A. 2003. Prebiotic concept for infant nutrition. 
Acta Paediatr. 91: 64-67. 
Boehm G, Jelinek J, Knol J, M'Rabet L, Stahl B, Vos P, et al. 2004. Prebiotics and immune 
responses. J Pediatr Gastroenterol Nutr. 39: S772-773. 
Boehm G, Lidestri M, Casetta P, Jelinek J, Negretti F, Stahl B, Marini A. 2002. 
Supplementation of a bovine milk formula with an oligosaccharide mixture increases 
counts of faecal Bifidobacteria in preterm infants. Arch Dis Child Fetal Neonatal Ed. 
86: F178-181. 
Boehm G, Stahl B, Jelinek J, Knol J, Miniello V, Moro GE. 2005. Prebiotic carbohydrates in 
human milk and formulas. Acta Pediatrica. 94: 18-21. 
Boling SD, Webel DM, Mavromichalis I, Parsons CM, Baker DH. 2000. The effects of citric 
acid on phytate phosphorus utilization in young chicks and pigs. J Anim Sci. 78: 682-
689. 
Boling-Frankenbach SD, Snow JL, Parsons CM, Baker DH. 2001. The effect of citric acid on 
the calcium and phosphorus requirements of chicks fed corn-soybean meal diets. 
Poult Sci. 80: 783-788. 
Bosund I. 1962. The action of benzoic and salicylic acids on the metabolism of 
microorganisms. Adv Food Res. 11: 331-353. 
Bouvet JP, Fischetti VA. 1999. Diversity of antibody-mediated immunity at the mucosal 
barrier. Infect Immun. 67: 2687-2691. 
Bovee-Oudenhoven IM, ten Bruggencate SJ, Lettink-Wissink ML, vander Meer R. 2003. 
Dietary fructo-oligosaccharides and lactulose inhibit intestinal colonization but 
stimulate translocation of salmonella in rats. Gut. 52: 1572-1578. 
Bovee-Oudenhoven IM, Termont DS, Heidt PJ, Van der Meer R. 1997. Increasing the 
intestinal resistance of rats to the invasive pathogen Salmonella enteritidis: additive 
effects of dietary lactulose and calcium. Gut. 40: 497-504. 
Brennan J, Skinner J, Barnum DA, Wilson J. 2003. The efficacy of bacitracin methylene 
disalicylate when fed in combination with narasin in the management of necrotic 
enteritis in broiler chickens. Poult Sci. 82: 360-363. 
Brul S, Coote P. 1999. Review: Preservative agents in foods - mode of action and microbial 
resistance mechanisms. Int J Food Microbiol. 50: 1-17. 
Buddington KK, Donahoo JB, Buddington RK. 2002. Dietary oligofructose and inulin protect 
mice from enteric and systemic pathogens and tumor inducers. J Nutr. 132: 472-477. 
Buhler K, Wenk C, Broz J, Gebert S. 2006. Influence of benzoic acid and dietary protein 
level on performance, nitrogen metabolism and urinary pH in growing-finishing pigs. 
Arch Anim Nutr. 60: 382-390. 
Campbell JM, Fahy GC, Wolf BW. 1997. Selected indigestible oligosaccharides affect large 
bowel mass and fecal short chain fatty acids (SCFAs), pH and microflora in rats. J 
Nutr. 127: 130-136. 
Chaveerach P, Keuzenkamp DA, Lipman LJA, Van Knapen F. 2004. Effect of organic acids 
in drinking water for young broilers on Campylobacter infection, volatile fatty acid 
production, gut microflora and histological cell changes. Poult Sci. 83: 330-334. 
Chen CC, Walker WA. 2005. Probiotics and prebiotics: role in clinical disease states. Adv 
Pediatr. 52: 77-113. 
Chu SHW, Nesheim MC. 1979. The relationship of plasma arginine and kidney arginase 
activity to arginine degradation in chickens. J Nutr. 109: 1752-1758. 
Coon CN, Leske KL, Akavanichan O, Cheng TK. 1990. Effect of oligosaccharide-free 
soybean meal on true metabolizable energy and fiber digestion in adult roosters. Poult 
Sci. 69: 787-793. 
Corzo A, Kidd MT, Burnham DJ, Kerr BJ. 2004. Dietary glycine needs of broiler chicks. 
Poult Sci. 83: 1382-1384. 
Czerwiński J, HØjberg O, Mulikowska S, Engberg RM, Mieczkowska A. 2010. Influence of 
dietary peas and organic acids and probiotic supplementation on performance and 
caecal microbial ecology of broiler chickens. Br Poult Sci. 51: 258-269. 
Davis LMG, Martinez I, Walter J, Goin C, Hutkins RW. 2011. Barcoded pyrosequencing 
reveals that consumption of galactooligosaccharides results in a highly specific 
bifidogenic response in humans. PLoS One. 6: e25200. 
Davis LMG, Martinez I, Walter J, Hutkins R. 2010. A dose dependent impact of prebiotic 
galactooligosaccharides on the intestinal microbiota of healthy adults. Int J Food 
Microbiol. 144: 285-292. 
de Waard R, Claassen E, Bokken GC, Buiting B, Garssen J, Vos JG. 2003. Enhanced 
immunological memory responses to Listeria monocytogenes in rodents, as measured 
by delayed-type hypersensitivity (DTH), adoptive transfer of DTH, and protective 
immunity, following Lactobacillus casei Shirota ingestion. Clin Diagn Lab Immunol. 
10: 59-65. 
Depeint F, Tzortzis G, Vulevic J, I'Anson K, Gibson GR. 2008. Prebiotic evaluation of a 
novel galactooligosaccharide mixture produced by the enzymatic activity of 
Bifidobacterium bifidum NCIMB 41171, in healthy humans: a randomized, 
doubleblind, crossover, placebo-controlled intervention study. Am J Clin Nutr. 87: 
785-791. 
Dibner JJ, Richards JD. 2005. Antibiotic growth promoters in agriculture: history and mode 
of action. Poult Sci. 84: 634-643. 
Dixon RC, Hamilton PB. 1981. Effects of feed ingredients on the antifungal activity of 
propionic acid. Poult Sci. 60: 2407-2411. 
Dubert-Ferrandon A, Nanthakumar N, Rautava S. 2008. Direct immunomodulatory 
properties of galactooligosaccharides on TNF-a mediated inflammation in human 
intestinal epithelial cells. World Congress Pediatr Gastroenterol Hepatol Nutr. 
WCPGHAN Iguassu Falls, Brazil. 
Duncan SH, Louis P, Thomson JM, Flint HJ. 2009. The role of pH in determining the species 
composition of the human colonic microbiota. Environ Microbiol. 11: 2112-2122. 
Durst L. 1996. Inclusion of fructo- and galacto-oligosaccharides in broiler diets. Arch 
Geflügelkd. 60: 160-164. 
Eidelsburger U, Kirchgessner M, Roth FX. 1992. Zum Einfluß von ameisensaure, 
calciumformiat und natriumhydrogencarbonat auf pH-Wert, trockenmassegehalt, 
konzentration an carbonsauren und ammoniak in verschiedenen segmenten des 
gastrointestinaltraktes. J Anim Physiol Anim Nutr. 68: 20-32. 
Ewaschuk JB, Dieleman LA. 2006. Probiotics and prebiotics in chronic inflammatory bowel 
diseases. World J Gastroenterol. 12: 5941-5950. 
Fanaro S, Vigi V, Chierici R, Boehm G. 2003. Fecal flora measurements of breastfed infants 
using an integrated transport and culturing system. Acta Paediatr. 92: 634-635. 
Favier C, Neut C, Mizon C, Cortot A, Colombel JF, Mizon J. 1997. Fecal beta-D-
galactosidase production and Bifidobacteria are decreased in Crohn’s disease. Dig Dis 
Sci. 42: 817-822. 
Feighner SD, Dashkevicz MP. 1987. Sub-therapeutic levels of antibiotics in poultry feeds and 
their effects on weight gain, feed efficiency, and bacterial cholyltaurine hydrolase 
activity. Appl Environ Microbiol. 53: 331-336. 
Field CJ. 2005. The immunological components of human milk and their effect on immune 
development in infants. J Nutr. 135: 1-4. 
Franklin MA, Mathew AG, Vickers JR. Clift RA. 2002. Characterization of microbial 
populations and volatile fatty acid concentrations in the jejunum, ileum, and cecum of 
pigs weaned at 17 vs 24 days of age. J Anim Sci. 80: 2904-2910. 
Fukushima Y, Kawata Y, Hara H, Terada A, Mitsuoka T. 1998. Effect of a probiotic formula 
on intestinal immunoglobulin A production in healthy children. Int J Food Microbiol. 
42: 39-44. 
Fuller R. 1977. The importance of lactobacilli in maintaining normal microbial balance in the 
crop. Br Poult Sci. 18: 85-94. 
George BA, Quarles CL, Fagerberg DJ. 1982. Virginiamycin effects on controlling necrotic 
enteritis infections in chickens. Poult Sci. 61: 447-450. 
Gibson GR, Probert HM, Loo JV, Rastall RA, Roberfroid MB. 2004. Dietary modulation of 
the human colonic microbiota: Updating the concept of prebiotics. Nutr Res Rev. 17: 
259-275. 
Gibson GR, Roberfroid MB. 1995. Dietary modulation of human colonic microbiota: 
Introducing the concept of prebiotics. J Nutr. 125: 1401-1412. 
Gill HS, Rutherfurd KJ, Cross ML. 2001. Dietary probiotic supplementation enhances natural 
killer cell activity in the elderly: an investigation of age-related immunological 
changes. J Clin Immunol. 21: 264-271. 
Goodarzi Boroojeni F, Mader A, Knorr F, Ruhnke I, Röhe I, Hafeez A, Männer K, Zentek J. 
2014b. The effects of different thermal treatments and organic acid levels on nutrient 
digestibility in broilers. Poult Sci. 93: 1159-1171. 
Goodarzi Boroojeni F, Vahjen W, Mader A, Knorr F, Ruhnke I, Röhe I, Hafeez A, Villodre 
C, Männer K, Zentek J. 2014a. The effects of different thermal treatments and organic 
acid levels in feed on microbial composition and activity in gastrointestinal tract of 
broilers. Poult Sci. 93: 1440-1452. 
Gopal PK, Prasad J, Gill HS. 2003. Effects of the consumption of Bifidobacterium lactis 
HN019 (DR10TM) and galacto-oligosaccharides on the microflora of the 
gastrointestinal tract in human subjects. Nutr Res. 23: 1313-1328. 
Gopalakrishnan A, Clinthorne JF, Rondini EA, McCaskey SJ, Gurzell EA, Langohr IM, 
Gardner EM, Fenton JI. 2012. Supplementation with galacto-oligosaccharides 
increases the percentage of NK cells and reduces colitis severity in Smad3-deficient 
mice. J Nutr. 142: 1336-1342. 
Gori A, Rizzardini G, Vant Land B, Amor KB, van Schaik J, Torti C, Quirino T, Tincati C, 
Bandera A, Knol J, Benlhassan-Chahour K, Trabattoni D, Bray D, Vriesema A, 
Welling G, Garssen J, Clerici M. 2011. Specific prebiotics modulate gut microbiota 
and immune activation in HAART-naive HIV infected adults: results of the "COPA" 
pilot randomized trial. Mucosal Immunol. 4: 554-563. 
Guggenbuhl P, Seon A, Quintana AP, and Nunes CS. 2007. Effects of dietary 
supplementation with benzoic acid (VevoVitall) on the zootechnical performance, the 
gastrointestinal microflora and the ileal digestibility of the young pig. Livest Sci. 108: 
218-221. 
Haarman M, Knol J. 2005. Quantitative real-time PCR assays to identify and quantify fecal 
Bifidobacterium species in infants receiving a prebiotic infant formula. Appl Environ 
Microbiol. 71: 2318-2324. 
Hamer DH. 2002. From the farm to the kitchen table: The negative impact of antimicrobial 
use in animals on humans. Nutr Rev. 60: 261-264. 
Hanson LA, Korotkova M, Lundin S, Haversen L, Silfverdal SA, Mattsby-Baltzer I, 
Strandvik B, Telemo E. 2003. The transfer of immunity from mother to child. Ann N 
Y Acad Sci. 987: 199-206. 
Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, Wagendorp AA, Klijn N, Bindels JG, 
Welling GW. 2000. Analysis of intestinal flora development in breast-fed and 
formula-fed infants by using molecular identification and detection methods. J Pediatr 
Gastroenterol Nutr. 30: 61-67. 
Hayakawa K, Mizutani J, Wada K, Masai T, Yoshihara I, Mitsuoka T. 1990. Effects of 
soybean oligosaccharides on human faecal flora. Microb Ecol Health Dis. 3: 293-303. 
Hebeler S, Kulla S, Winkenwerder F, Kamphues J, Zentek J, Amtsberg G. 2000. Einfluß 
eines ameisensaure-kaliumformiat-komplexes auf die zusammensetzung des chymus 
sowie die mikroflora im darmkanal von absatzferkeln. Proc Soc Nutr Physiol. 9: 63. 
Hernandez F, Garcia V, Madrid J, Orengo J, Catala P, Megias MD. 2006. Effect of formic 
acid on performance, digestibility, intestinal histomorphology and plasma metabolite 
levels of broiler chickens. Br Poult Sci. 47: 50-56. 
Hornung M, Werner JM, Farkas S, Schlitt HJ, Geissler EK. 2011. Migration and chemokine 
receptor pattern of colitis-preventing DX5(+)NKT cells. Int J Colorectal Dis. 26: 
1423-1433. 
Hume ME. 2011. Historic perspective: Prebiotics, probiotics, and other alternatives to 
antibiotics. Poult Sci. 90: 2663-2669. 
Huyghebaert G, Ducatelle R, van Immerseel F. 2011. An update on alternatives to 
antimicrobial growth promoters for broilers. Vet J. 187: 182-188.  
Inoue S, Unsinger J, Davis CG, Muenzer JT, Ferguson TA, Chang K, Osborne DF, Clark AT, 
Coopersmith CM, McDunn JE, Hotchkiss RS. 2010. IL-15 prevents apoptosis, 
reverses innate and adaptive immune dysfunction, and improves survival in sepsis. J 
Immunol. 184: 1401-1409. 
Ito M, Deguchi Y, Miyamori A, Kikuchi H, Matsumoto K, Kobayashi Y, Yajiama T, Kan T. 
1990. Effects of administration of galactooligosaccharides on human faecal 
microflora, stool weight and abdominal sensation. Microb Ecol Health Dis. 3: 285-
292. 
Jamroz D, Jakobsen K, Bach Knudsen KE, Wiliczkiewicz A, Orda J. 2002. Digestibility and 
energy value of the non-starch polysaccharides in young chickens, ducks and geese, 
fed diets containing high amounts of barley. Comp Biochem Physiol. 131: 657-668. 
Jay JM. 1992. Modern Food Microbiology. Van Nostrand Reinhold, New York. pp. 701. 
Józefiak D, Kaczmarek S, Bochenek M, Rutkowski A. 2007. A note on effects of benzoic 
acid supplementation on the performance and microbiota populations of broiler 
chickens. J Anim Feed Sci. 16: 252-256. 
Józefiak D, Kaczmarek S, Rutkowski A. 2010. The effects of benzoic acid supplementation 
on the performance of broiler chickens. J Anim Physiol Anim Nutr. 94: 29-34. 
Juelke K, Killig M, Luetke-Eversloh M, Parente E, Gruen J, Morandi B, Ferlazzo G, Thiel A, 
Schmitt-Knosalla I, Romagnani C. 2010. CD62L expression identifies a unique subset 
of polyfunctional CD56dim NK cells. Blood. 116: 1299-1307. 
Jung SJ, Houde R, Baurhoo B, Zhao X, Lee BH. 2008. Effects of galacto-oligosaccharides 
and a bifidobacteria lactis-based probiotic strain on the growth performance and fecal 
microflora of broiler chickens. Poult Sci. 87: 1694-1699.  
Jung SJ, Lee BH. 2008. Production and application of galacto-oligosaccharides from lactose 
by a recombinant β-galactosidase of Bifidobacterium infantis overproduced by Pichia 
pastoris. Food Sci Biotechnol. 17: 514-518. 
Kanakupt K, Vester Boler BM, Dunsford BR, Fahey Jr GC. 2011. Effects of short-chain 
fructooligosaccharides and galactooligosaccharides, individually and in combination, 
on nutrient digestibility, fecal fermentative metabolite concentrations, and large bowel 
microbial ecology of healthy adults cats. J Anim Sci. 89: 1376-1384. 
Kelly-Quagliana KA, Nelson PD, Buddington RK. 2003. Dietary oligofructose and inulin 
modulate immune functions in mice. Nutr Res. 23: 257-267. 
Kluge H, Broz J, Eder K. 2006. Effect of benzoic acid on growth performance, nutrient 
digestibility, nitrogen balance, gastrointestinal microflora and parameters of microbial 
metabolism in piglets. J Anim Physiol Anim Nutr. 90: 316-324. 
Kluge H, Broz J, Eder K. 2010. Effects of dietary benzoic acid on urinary pH and nutrient 
digestibility in lactating sows. Livest Sci. 134: 119-121. 
Knarreborg A, Lauridsen C, Engberg RM, Jensen SK. 2004. Dietary antibiotic growth 
promoters enhance the bioavailability of alpha-tocopheryl acetate in broilers by 
altering lipid absorption. J Nutr. 134: 1487-1492. 
Knarreborg A, Miquel N, Granli T, Jensen BB. 2002. Establishment and application of an in 
vitro methodology to study the effects of organic acids on coliform and lactic acid 
bacteria in the proximal part of the gastrointestinal tract of piglets. Anim Feed Sci 
Technol. 99: 131-140. 
Kneifel W, Rajal A, Kulbe KD. 2000. In vitro growth behaviour of probiotic bacteria in 
culture media with carbohydrates of prebiotic importance. Microb Ecol Health Dis. 
12: 27-34. 
Knol J, Scholtens P, Kafka C, Steenbakkers J, Gro S, Helm K, Klarczyk M, Schopfer H, 
Bockler HM, Wells J. 2005. Colon microflora in infants fed formula with galacto- and 
fructo-oligosaccharides: more like breast-fed infants. J Pediatr Gastroenterol Nutr. 40: 
36-42. 
Kuitunen M, Savilahti E. 1995. Mucosal IgA, mucosal cow’s milk antibodies, serum cow’s 
milk antibodies and gastrointestinal permeability in infants. Pediatr Allergy Immunol. 
6: 30-35. 
Kulla S. 2001. Untersuchungen zum einfluss von kaliumdiformiat als futterzusatz auf das 
keimspektrum und parameter des mikrobiellen stoffwechsels im chymus sowie 
verschiedenen verdauungsprozesse von absetzferkeln. Dissertation, Hannover. 
Langhendries JP, Detry J, Van Hees J, Lamboray JM, Darimont J, Mozin MJ, Secretin MC, 
Senterre J. 1995. Effect of a fermented infant formula containing viable bifidobacteria 
on the fecal flora composition and pH of healthy full-term infants. J Pediatr 
Gastroenterol Nutr. 21: 177-181. 
Liem A, Pesti GM, Edwards HM. 2008. The effect of several organic acids on phytate 
phosphorus hydrolysis in broiler chicks. Poult Sci. 87: 689-693. 
Liu Z, Geboes K, Colpaert S, D’Haens GR, Rutgeerts P, Ceuppens JL. 2000. IL-15 is highly 
expressed in inflammatory bowel disease and regulates local T cell-dependent 
cytokine production. J Immunol. 164: 3608-3615. 
Macfarlane S, Macfarlane GT, Cummings JH. 2006. Prebiotics in the gastrointestinal tract. 
Aliment Pharmacol Ther. 24: 701-714. 
Makelainen H, Saarinen M, Stowell J, Rautonen N, Ouwehand AC. 2010. Xylo-
oligosaccharides and lactitol promote the growth of Bifidobacterium lactis and 
Lactobacillus species in pure cultures. Ben Microbes. 1: 139-148. 
Malinen E, Mättö J, Salmitie M, Alander M, Saarela M, Palva A. 2002. PCR-ELISA II: 
Analysis of Bifidobacterium populations in human faecal samples from a 
consumption trial with Bifidobacterium lactis Bb-12 and a galacto-oligosaccharide 
preparation. Syst Appl Microbiol. 25: 249-258. 
Manhart N, Spittler A, Bergmeister H, Mittlbock M, Roth E. 2003. Influence of 
fructooligosaccharides on Peyer's patch lymphocyte numbers in healthy and 
endotoxemic mice. Nutrition. 19: 657-660. 
Martinez I, Kim J, Duffy PR, Schlegel VL, Walter J. 2010. Resistant starches types 2 and 4 
have differential effects on the composition of the fecal microbiota in human subjects. 
PLoS One. 5: e15046. 
Maukonen J, Matto J, Kajander K, Mattila-Sandholm T, Saarela M. 2008. Diversity and 
temporal stability of fecal bacterial populations in elderly subjects consuming galacto-
oligosaccharide containing prebiotic yoghurt. Int Dairy J. 18: 386-395. 
Mazanec MB, Nedrud JG, Kaetzel CS, Lamm ME. 1993. A three-tiered view of the role of 
IgA in mucosal defense. Immunol Today. 14: 430-435. 
Metwally A. 2001. Influence of supplemental citric acid and sodium and potassium citrate on 
phytate-phosphorus utilization in broiler chicks fed phosphorus-deficient diets from 
one to 42 days of age. Poult Sci. 80: 135. 
Middelbos IS, Fastinger ND, Fahey Jr GC. 2007. Evaluation of fermentable oligosaccharides 
in diets fed to dogs in comparison to fiber standards. J Anim Sci. 85: 3033-3044. 
Molis C, Flourie B, Ouarne F, Gailing MF, Lartigue S, Guibert A, Bornet F, Galmiche JP. 
1996. Digestion, excretion, and energy value of fructooligosaccharides in healthy 
humans. Am J Clin Nutr. 64: 324-328. 
Morgan AJ, Mul AJ, Beldman G, Voragen AGJ. 1992. Dietary oligosaccharides - new 
insights. AGRO Fd Indust High Technol Nov/Dec. 3: 35-38. 
Moro GE, Minoli I, Mosca M, Fanaro S, Jelinek J, Stahl B, Boehm G. 2002. Dosage-related 
bifidogenic effects of galacto- and fructo-oligosaccharide in formula fed term infants. 
J Paediatr Gastroenterol Nutr. 34: 291-295. 
Moro GE, Mosca F, Miniello V, Fanaro S, Jelinek J, Stahl B, Boehm G. 2003. Effects of a 
new mixture of prebiotics on faecal flora and stools in term infants. Acta Paediatr. 91: 
77-79. 
Mountzouris KC, Xypoleas I, Kouseris I, Fegeros K. 2006. Nutrient digestibility, faecal 
physicochemical characteristics and bacterial glycosidic activity of growing pigs fed a 
diet supplemented with oligofructose or trans-galactooligosaccharides. Livest Sci. 
105: 168-175. 
Mroz Z, Jongbloed AW, Partanen KH, Vreman K, Kemme PA, Kogut J. 2000. The effects of 
calcium benzoate in diets with or without organic acids on dietary buffering capacity, 
apparent digestibility, retention of nutrients and manure characteristics in swine. J 
Anim Sci. 78: 2622-2632. 
Mueller S, Saunier K, Hanisch C, Norin E, Alm L,Midtvedt T, Cresci A, Silvi S, Orpianesi C, 
Verdenelli MC, Clavel T, Koebnick C, Zunft HJ, Doré J, Blaut M. 2006. Differences 
in fecal microbiota in different European study populations in relation to age, gender, 
and country: a cross-sectional study. Appl Environ Microbiol. 72: 1027-1033. 
Mullie C, Yazourh A, Thibault H, Odou MF, Singer E, Kalach N, Kremp O, Romond MB. 
2004. Increased poliovirus-specific intestinal antibody response coincides with 
promotion of Bifidobacterium longum-infantis and Bifidobacterium breve in infants: a 
randomized, double-blind, placebo controlled trial. Pediatr Res. 56: 791-795. 
Nagura T, Hachimura S, Hashiguchi M, Ueda Y, Kanno T, Kikuchi H, Sayama K, 
Kaminogawa S. 2002. Suppressive effect of dietary raffinose on T-helper 2 cell-
mediated immunity. Br J Nutr. 88: 421-426. 
Nakamura Y, Nosaka S, Suzuki M, Nagafuchi S, Takahashi T, Yajima T, Takenouchi-
Ohkubo N, Iwase T, Moro I. 2004. Dietary fructooligosaccharides up-regulate 
immunoglobulin A response and polymeric immunoglobulin receptor expression in 
intestines of infant mice. Clin Exp Immunol. 137: 52-58. 
Nava GM, Attene-Ramos MS, Gaskins HR, Richards JD. 2009. Molecular analysis microbial 
community structure in the chicken ileum following organic acids supplementation. 
Vet Microbiol. 137: 345-353. 
Nesheim MC, Garlich JD. 1963. Studies on ornithine synthesis in relation to benzoic acid 
excretion in the domestic fowl. J Nutr. 79: 311-317. 
Niewold TA. 2007. The nonantibiotic anti-inflammatory effect of antimicrobial growth 
promoters, the real mode of action? A hypothesis. World Poult Sci J. 86: 605-609. 
Niness KR. 1999. Inulin and oligofructose: What are they? J Nutr. 129: 1402S-1406S. 
Nishimura M, Kuboi Y, Muramoto K, Kawano T, Imai T. 2009. Chemokines as novel 
therapeutic targets for inflammatory bowel disease. Ann N Y Acad Sci. 1173: 350-
356. 
Olano-Martin E, Williams MR, Gibson GR, Rastall RA. 2003. Pectins and pectic-
oligosaccharides inhibit Escherichia coli O157 H7 shiga toxin as directed towards the 
human colonic cell line HT27. FEMS Microbiol Lett. 218: 101-105. 
Parracho H, McCartney AL, Gibson GR. 2007. Probiotics and prebiotics in infant nutrition. 
Proc Nutr Soc. 66: 405-411. 
Partanen K, Mroz Z. 1999. Organic acids for performance enhancement in pig diets. Nutr Res 
Rev. 12: 117-145. 
Paster N. 1979. A commercial scale study of the efficiency of propionic acid and calcium 
propionate as fungistats in poultry feed. Poult Sci. 58: 572-576. 
Patterson JA, Burkholder KM. 2003. Application of prebiotics and probiotics in poultry 
production. Poult Sci. 82: 627-631. 
Pelicano ERL, de Souza PA, de Souza HBA, Leonel FR, Zeola NMBL, Boiago MM. 2004. 
Productive traits of broiler chickens fed diets containing different growth promoters. 
Rev Bras Cienc Avicola. 6: 177-182. 
Penders J, Thijs C, van den Brandt PA, Kummeling I, Snijders B, Stelma F, Adams H, van 
Ree R, Stobberingh EE. 2007. Gut microbiota composition and development of atopic 
manifestations in infancy: the KOALA Birth Cohort Study. Gut. 56: 661-667. 
Pierre F, Perrin P, Bassonga E, Bornet F, Meflah K, Menanteau J. 1999. T cell status 
influences colon tumor occurrence in min mice fed short chain fructo-
oligosaccharides as a diet supplement. Carcinogenesis. 20: 1953-1956. 
Pierre F, Perrin P, Champ M, Bornet F, Meflah K, Menanteau J. 1997. Short-chain fructo-
oligosaccharides reduce the occurrence of colon tumors and develop gut-associated 
lymphoid tissue in Min mice. Cancer Res. 57: 225-228. 
Pirgozliev V, Murphy TC, Owens B, George J, McCann MEE. 2008. Fumaric and sorbic acid 
as additives in broiler feed. Res Vet Sci. 84: 387-394. 
Pölönen I, Toivonen V, Mäkelä J. 1998: Different combinations of formic, propionic and 
benzoic acids in slaughter offal preservation for feeding to fur animals. Anim Feed 
Sci Technol. 71: 197-202. 
Pölönen IJ, Partanen KH, Jalava TK, Toivonen VF. 2000. Effect of dietary glycine and 
benzoate level on benzoate metabolism in mink (Mustela vison), blue fox (Alopex 
lagopus), and raccoon dog (Nyctereutes procyonoides). J Anim Sci. 78: 976-986. 
Prenosil JE, Stuker E, Bourne JR. 1987. Formation of oligosaccharides during enzymic 
lactose hydrolysis. I. State of the art. Biotechnol Bioeng. 30: 1019-1025. 
Rafacz-Livingston KA, Martinez-Amezcua C, Parsons CM, Baker DH, Snow J. 2005b. Citric 
acid improves phytate phosphorus utilization in crossbred and commercial broiler 
chicks. Poult Sci. 84: 1370-1375. 
Rafacz-Livingston KA, Parsons CM, Jungk RA. 2005a. The effects of various organic acids 
on phytate phosphorus utilization in chicks. Poult Sci. 84: 1356-1362. 
Reddy BS. 1999. Possible mechanisms by which pro- and prebiotics influence colon 
carcinogenesis and tumor growth. J Nutr. 129: 1478S-1482S. 
Rehman H, Hellweg P, Taras D, Zentek J. 2008. Effects of dietary inulin on the intestinal 
short chain fatty acids and microbial ecology in broiler chickens as revealed by 
denaturing gradient gel electrophoresis. Poult Sci. 87: 783-789. 
Reimer RA, Thomson ABR, Rajotte RV, Basu TK, Ooraikul B, McBurney MI. 1997. A 
physiological level of rhubarb fiber increases proglucagon gene expression and 
modulates intestinal glucose uptake in rats. J Nutr. 127: 1923–1928. 
Ricke SC. 2003. Perspectives on the use of organic acids and short chain fatty acids as 
antimicrobials. Poult Sci. 82: 632-699. 
Roberfroid M. 2007. Prebiotics: The concept revisited. J Nutr. 137: 830S-837S. 
Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, Wolvers D, 
Watzl B, Szajewska H, Stahl B, Guarner F, Respondek F, Whelan K, Coxam V, 
Davicco MJ, Léotoing L, Wittrant Y, Delzenne NM, Cani PD, Neyrinck AM, 
Meheust A. 2010. Prebiotic effects: metabolic and health benefits. Br J Nutr. 104: S1-
63. 
Roller M, Rechkemmer G, Watzl B. 2004. Prebiotic inulin enriched with oligofructose in 
combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis 
modulates intestinal immune functions in rats. J Nutr. 134: 153-156. 
Roth FX, Eckel B, Kirchgessner M, Eidelsburger U. 1992. Zum Einfluß von ameisensaure 
auf pH-Wert, trockenmassegehalt, konzentration an fluchtigen fettsauren und 
milchsaure im gastrointestinaltrakt. J Anim Physiol Anim Nutr. 67: 148-156. 
Rowland IR, Tanaka R. 1993. The effects of transgalactosylated oligosaccharides on gut flora 
metabolism in rats associated with a human faecal microflora. J Appl Bacteriol. 74: 
667-674. 
Rubaltelli FF, Biadaioli R, Pecile P, Nicoletti P. 1998. Intestinal flora in breast- and bottle-
fed infants. J Perinat Med. 26: 186-191. 
Russell JB. 1992. A review: Another explanation for the toxicity of fermentation acids at low 
pH: Anion accumulation versus uncoupling. J Appl Bacteriol. 73: 363-370. 
Sacakli P, Sehu A, Ergun A, Genc B, Selcuk Z. 2006. The effect of phytase and organic acid 
on growth performance, carcass yield and tibia ash in quails fed diets with low levels 
of non-phytate phosphorus. Asian-Australasian J Anim Sci. 19: 198-202. 
Saito Y, Tanaka T, Rowland IR. 1992. Effects of soybean oligosaccharides on the human gut 
microflora in vitro culture. Microb Ecol Health Dis. 5: 105-110. 
Sakai T, Kusugami K, Nishimura H, Ando T, Yamaguchi T, Ohsuga M, Ina K, Enomoto A, 
Kimura Y, Yoshikai Y. 1998. Interleukin 15 activity in the rectal mucosa of 
inflammatory bowel disease. Gastroenterology. 114: 1237-1243. 
Schmelzle H, Wirth S, Skopnik H, Radke M, Knol J, Bockler HM, Brönstrup A, Wells J, 
Fusch C. 2003. Randomized double-blind study of the nutritional efficacy and 
bifidogenicity of a new infant formula containing partially hydrolyzed protein, a high 
beta-palmitic acid level, and nondigestible oligosaccharides. J Pediatr Gastroenterol 
Nutr. 36: 343-351. 
Scholtens PA, Alles MS, Bindels JG, van der Linde EG, Tolboom JJ, Knol J. 2006. 
Bifidogenic effects of solid weaning foods with added prebiotic oligosaccharides: A 
randomised controlled clinical trial. J Pediatr Gastroenterol Nutr. 42: 553-559. 
Scholtens PAMJ, Alliet P, Raes M, Alles MS, Kroes H, Boehm G, Knippels LMJ, Knol J, 
Vandenplas Y. 2008. Fecal secretory immunoglobulin A is increased in healthy 
infants who receive a formula with short-chain galacto-oligosaccharides and long-
chain fructo-oligosaccharides. J Nutr. 138: 1141-1147. 
Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, Marteau P, Jian R, Dore J. 2003. 
Alterations of the dominant faecal bacterial groups in patients with Crohn’s disease of 
the colon. Gut. 52: 237-242. 
Silbergeld EK, Graham J, Price LB. 2008. Industrial food animal production, antimicrobial 
resistance, and human health. Annu Rev Public Health. 29: 151-169. 
Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR. 2009. Clinical trial: the effects of a 
trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable 
bowel syndrome. Aliment Pharmacol Ther. 29: 508-518. 
Sims MD, Dawson KA, Newman KE, Spring P, Hooge DM. 2004. Effects of dietary mannan 
oligosaccharide, bacitracin methylene disalicylate, or both on the live performance 
and intestinal microbiology of turkeys. Poult Sci. 83: 1148-1154. 
Smiricky-Tjardes MR, Grieshop CM, Flickinger EA, Bauer LL, Fahey GC. 2003. Dietary 
galactooligosaccharides affect ileal and total-tract nutrient digestibility, ileal and fecal 
bacterial concentrations, and ileal fermentative characteristics of growing pigs. J 
Anim Sci. 81: 2535-2545. 
Smith JW, Tokach MD, Goodband RD, Nelssen JL, Richert BT. 1997. Effects of the 
interrelationship between zinc oxide and copper sulfate on growth performance of 
early-weaned pigs. J Anim Sci. 75: 1861-1866. 
Snow JL, Baker DH, Parsons CM.. 2004. Phytase, citric acid, and 1α-hydroxycholecalciferol 
improve phytate phosphorus utilization in chicks fed a corn-soybean meal diet. Poult 
Sci. 83: 1187-1192. 
Snyder DL, Wostmann BS. 1987. Growth rate of male germfree Wistar rats fed ad libitum or 
restricted natural ingredient diet. Lab Anim Sci. 37: 320-325. 
Sonoyama K, Watanabe H, Watanabe J, Yamaguchi N, Yamashita A, Hashimoto H, Kishino 
E, Fujita K, Okada M, Mori S, Kitahata S, Kawabata J. 2005. Allergic airway 
eosinophilia is suppressed in ovalbumin-sensitized Brown Norway rats fed raffinose 
and alpha-linked galactooligosaccharide. J Nutr. 135: 538-543. 
Sou. 1997. Antimicrobial feed additives. Report from the commission on antimicrobial feed 
additives. Government official report. Ministry of agriculture: Stockholm, pp. 132. 
Stanczuk J, Zdunczyk Z, Juskiewicz J, Jankowski J. 2005. Indices of response of young 
turkeys to diets containing mannanoligosaccharide or inulin. Vet Zootech. 31: 98-101. 
Suzuki K, Meek B, Doi Y, Muramatsu M, Chiba T, Honjo T, Fagarasan S. 2004. Aberrant 
expansion of segmented filamentous bacteria in IgA deficient gut. Proc Natl Acad Sci 
USA. 101: 1981-1986. 
Swanson KS, Grieshop CM, Flickinger EA, Bauer LL, Healy HP, Dawson KA, Merchen NR, 
Fahey Jr GC. 2002a. Supplemental fructooligosaccharides and 
mannanoligosaccharides influence immune function, ileal and total tract nutrient 
digestibilities, microbial populations and concentrations of protein catabolites in the 
large bowel of dogs. J Nutr. 132: 980-989. 
Swanson KS, Grieshop CM, Flickinger EA, Healy HP, Dawson KA, Merchen NR, Fahey Jr 
GC. 2002b. Effects of supplemental fructooligosaccharides plus 
mannanoligosaccharides on immune function and ileal and fecal microbial 
populations in adult dogs. Arch Anim Nutr. 56: 309-318. 
Tannock GW, Munro K, Bibiloni R, Simon MA, Hargreaves P, Gopal P, Harmsen H, 
Welling G. 2004. Impact of consumption of oligosaccharide-containing biscuits on 
the fecal microbiota of humans. Appl Environ Microbiol. 70: 2129-2136. 
Taper HS, Lemort C, Roberfroid MB. 1998. Inhibition effect of dietary inulin and 
oligofructose on the growth of transplantable mouse tumor. Anticancer Res. 18: 4123-
4126. 
Ten Bruggencate SJ, Bovee-Oudenhoven IM, Lettink-Wissink ML, Vander Meer R. 2003. 
Dietary fructo-oligosaccharides dose-dependently increase translocation of salmonella 
in rats. J Nutr. 133: 2313-2318. 
Terada A, Hara H, Kato S, Kimura T, Fujimori I, Hara K, Maruyama T, Mitsuoka T. 1993. 
Effect of lactosucrose (4G-β-d-galactoslysucrose) on fecal flora and fecal putrefactive 
products of cats. J Vet Med Sci. 55: 291-295. 
Thompson JL, Hinton M. 1997. Antibacterial activity of formic and propionic acids in the 
diet of hens on Salmonella in the crop. Br Poult Sci. 38: 59-65. 
Threlfall EJ, Ward LR, Frost JA, Willshaw GA. 2000. The emergence and spread of 
antibiotic resistance in food-borne bacteria. Int J Food Microbiol. 62: 1-5. 
Torrallardona D, Badiola I, Broz J. 2007. Effects of benzoic acid on performance and ecology 
of gastrointestinal microbiota in weanling piglets. Livest Sci. 108: 210-213. 
Tuohy KM, Ziemer CJ, Klinder A, Knobel Y, Pool-Zobel BL, Gibson GR. 2002. A human 
volunteer study to determine the prebiotic effects of lactulose powder on human 
colonic microbiota. Microb Ecol Health Dis. 14: 165-173. 
Tzortzis G, Goulas AK, Gee JM, Gibson GR. 2005. A novel galactooligosaccharide mixture 
increases the bifidobacterial population numbers in a continuous in vitro fermentation 
system and in the proximal colonic contents of pigs in vivo. J Nutr. 135: 1726-1731. 
Umemura M, Hirose K, Wajjwaiku W, Nishimura H, Matsuguchi T, Gotoh Y, Takahashi M, 
Makino M, Yoshikai Y. 2001. Impaired IL-15 production associated with 
susceptibility of murine AIDS to mycobacterial infection. J Leukoc Biol. 69: 138-148. 
Uraih N, Chipley JR. 1976. Effects of various acids and salts on growth and aflatoxin 
production by Aspergillus flavus NRRL 3145. Microbios. 67: 51-59. 
Van de Perre P. 2003. Transfer of antibody via mother’s milk. Vaccine. 21: 3374-3376. 
Van Immerseel F, Russell JB, Flythe MD, Gantois I, Timbermont L, Pasmans F, 
Haesebrouck F, Ducatelle R. 2006. The use of organic acids to combat Salmonella in 
poultry: a mechanistic explanation of the efficacy. Avian Pathol. 35: 182-188. 
Vos AP, Haarman M, Buco A, Govers M, Knol J, Garssen J, Stahl B, Boehm G, M'Rabet L. 
2006. A specific prebiotic oligosaccharide mixture stimulates delayed-type 
hypersensitivity in a murine influenza vaccination model. Int Immunopharmacol. 6: 
1277-1286. 
Vulevic J, Drakoularakou A, Yaqoob P, Tzortzis G, Gibson GR. 2008. Modulation of the 
fecal microflora profile and immune function by a novel trans-galactooligosaccharide 
mixture (β-GOS) in healthy elderly volunteers. Am J Clin Nutr. 88: 1438-1446. 
Waldmann TA, Tagaya Y. 1999. The multifaceted regulation of interleukin-15 expression 
and the role of this cytokine in NK cell differentiation and host response to 
intracellular pathogens. Annu Rev Immunol. 17: 19-49. 
Waldroup AL, Skinner JT, Hierholzer RE, Waldroup PE. 1993. An evaluation of 
fructooligosaccharide in diets for broiler chickens and effects on salmonellae 
contamination of carcasses. Poult Sci. 72: 643-650. 
Walker WA. 2000. Role of nutrients and bacterial colonization in the development of 
intestinal host defense. J Pediatr Gastroenterol Nutr. 30: S2-7. 
Wierup M. 2001. The Swedish experience of the 1986 ban of antimicrobial growth 
promoters, with special reference to animal health, disease prevention, productivity, 
and usage of antimicrobials. Microb Drug Resist. 7: 183-190. 
Wildgrube M, Zausch M. 1971. Silierung von Zuckerrüben. Tierzucht. 25: 90-93. 
Williams RT. 1959. Detoxication mechanisms. 2nd Edn. John Wiley and Sons Inc., NY. 
Windisch WM, Gotterbarm GG, Roth FX. 2001. Effect of potassium diformate in 
combination with different amounts and sources of excessive dietary copper on 
production performance in weaning piglets. Arch Anim Nutr. 54: 87-100. 
Winkenwerder F. 1999. Wirkungen gekapselter milchsaure bzw. eines gekapselten 
sauregemisches als futteradditiv auf die darmflora von absetzferkeln. Dissertation, 
Hannover. 
Xu ZR, Hu CH, Xia MS, Zhan XA, Wang MQ. 2003. Effects of dietary fructooligosaccharide 
on digestive enzyme activities, intestinal microflora and morphology of male broilers. 
Poult Sci. 82: 1030-1036. 
Yan F, Polk DB. 2010. Probiotics: progress toward novel therapies for intestinal diseases. 
Curr Opin Gastroenterol. 26: 95-101. 
Zentek J, Marquart B, Pietrzak T. 2002. Intestinal effects of mannooligosaccharides, 
transgalactooligosacchaides, lactose and lactulose in dogs. J Nutr. 132: S1682-S1684. 
Zhang C, Zhang J, Niu J, Tian Z. 2008. Interleukin-15 improves cytotoxicity of natural killer 
cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as 
STAT1 and ERK1/2 phosphorylation. Cytokine. 42: 128-136. 
CHAPTER 3 
EXPERIMENT 1 
 
Comparison of Different Dietary Concentrations of β-Galacto-Oligosaccharides on 
Growth Performance, Serum Metabolites, Selected Caecel Microbial Populations and 
Immune Response in Broilers 
3.1. INTRODUCTION 
Profitability in poultry production system depends upon a number of decisive factors 
like maximum nutrients digestibility, absorption, availability and conversion into valuable 
end products. In this regard, the gastrointestinal tract (GIT) health is a prime focus of interest 
because any impairment in gastrointestinal functioning and gut microbial dysbiosis can 
adversely affect the digestion, metabolism and availability of nutrients, resulting in poor 
growth performance, impaired feed efficiency and high mortality in birds (Dibner and 
Richards 2005). Gastrointestinal microbes, ubiquitous and heterogenous, play complex and 
important role in nutrition, metabolism, growth and health of growing animals (Dibner and 
Buttin 2002; Torok et al. 2011), the nutrients in the GIT are competitively partitioned 
between host-animal and gut microflora for energy. Therefore, more partitioning of nutrients 
towards the host-animal is another desirable factor that can positively influence the 
performance and health of growing animals. This is managed, in part, by fortification of 
poultry feed with sub-therapeutic levels of antibiotics (Huyghebaert et al. 2011). However, 
after the ban imposed by the European commission (2006) on the addition of antibiotics as 
growth promoters in feed, investigators and producers start seeking alternatives to antibiotics. 
The number of feed additives, termed as eubiotics, including prebiotics, probiotics, 
phytobiotics, essential oils, enzymes and organic acids are proposed to improve nutrient 
digestibility and utilization and gut health, which eventually improves overall performance of 
the birds (Wenk 2002; Huyghebaert et al. 2011). 
Prebiotics are group of substances which are oligosaccharides containing hexose 
monosaccharides like mannose, fructose, glucose and galactose (Durst 1996) with a different 
degree of polymerization (d.p.) ranging between two to twenty monosaccharides. Gibson et 
al. (2004) and Roberfroid (2007) defined prebiotics as “selectively fermentable carbohydrates 
that are resistant to gastric acidity and host hydrolytic enzymes, non-absorbable, fermented 
by GIT microbiota and allow specific changes, both in the composition and/or activity of one 
or a limited number of gastrointestinal microbiota that confer benefits upon host well-being 
and health”. Prebiotics include mannan-oligosaccharides, pectic-oligosaccharides, soybean-
oligosaccharides, isomalto-oligosaccharides, xylo-oligosaccharides, fructo-oligosaccharides, 
galacto-oligosaccharides, transgalactosylated oligosaccharides, inulin and lactulose (Morgan 
et al. 1992; Saito et al. 1992; Campbell et al. 1997; Tuohy et al. 2002; Zentek et al. 2002; 
Olano-Martin et al. 2003; Biggs et al. 2007; Macfarlane et al. 2006; Jung et al. 2008; Rehman 
et al. 2008).  
Galacto-oligosaccharides (GOS), d.p. between two to ten, are produced by enzymatic 
transgalactosylation of lactose by β-galactosidase (Prenosil et al. 1987) from different 
bacteria, yeast or fungi with variable glycosidic linkages (Ekhart and Timmermans 1996; 
Otieno 2010) based upon the enzyme source. In addition to the production of GOS, lactose 
fermentation also yields other non-prebiotic compounds like glucose and galactose. Prebiotic 
GOS has been studied in human beings (Moro et al. 2002; Boehm et al. 2005; Haarman and 
Knol 2005; Vulevic et al. 2008), pigs (Smiricky-Tjardes et al. 2003), rats (Rowland and 
Tanaka 1993), mice (Vos et al. 2006) and poultry (Biggs et al. 2007; Jung et al. 2008). These 
studies indicate that dietary GOS supplementation increases the populations of Bifidobacteria 
and Lactobacilli in feces or digesta. In addition to increasing populations of Bifidobacteria 
and Lactobacilli, GOS supplementation has been shown to enhance the delayed-type 
hypersensitivity response in a murine influenza vaccination model (Vos et al. 2006), natural 
killer cells activity in human beings (Vulevic et al. 2008) and mice (Gopalakrishnan et al. 
2012), and to decrease pro-inflammatory cytokines production in humans (Vulevic et al. 
2008). However, inclusion of GOS has no effects body weights, feed intake and feed 
conversion efficiency in poultry (Biggs et al. 2007; Jung et al. 2008) and pigs (Mountzouris 
et al. 2006). 
The aim of the present study was to investigate the effects of different dietary 
concentrations of β-galacto-oligosaccharides (BimunoTM, Clasado Limited, United 
Kingdom), produced by transgalactosylation of lactose by β-galactosidase of Bifidobacterium 
bifidum NCIMB 41171, on growth performance, feed conversion efficiency, organ 
characteristics, serum biochemical metabolites, selected caecel microbial populations and 
immune response of growing broilers. 
3.2. MATERIALS AND METHODS 
3.2.1. Experimental Design 
A total of 200, day-old broiler chicks (Hubbard), were purchased from a commercial 
hatchery (Big-birds Pvt.) and housed in an environmentally controlled shed (Phool-nagar, 
Pattoki) carpeted with wood shaving litter. The birds were equally divided into four treatment 
groups (n = 50/group) with five replicas (n = 10) in each treatment group. During the 
brooding period, first week, temperature was kept at 35 ± 1°C and relative humidity was 
maintained at 65 ± 5%. Temperature was decreased 3°C on a weekly basis and maintained at 
26°C for the rest of experimental period, whereas, relative humidity was kept constant at 65 ± 
5%. The birds were fed a corn-based basal diet (Annexure; Table I), formulated free of 
antimicrobials and coccidiostats to meet or exceed the recommendations of the "National 
Research Council" (NRC 1994), or same basal diet supplemented with different 
concentrations of β-galacto-oligosaccharides (β-GOS). The β-GOS power mixture contains 
"monosaccharides 15-17%, lactose 22%, disaccharides 18-25%, trisaccharides 20-25%, 
tetrasaccharides 8-12% and pentasaccharides 7-10%". 
Four experimental diets were prepared by mixing 0%, 0.1%, 0.2% and 0.5% β-GOS 
and fed to the experimental birds. The birds in the control (β-GOS-0) group were provided 
basal diet (0% β-GOS) and birds in other groups were provided same diets supplemented 
with 0.1% β-GOS (β-GOS-1), 0.2% β-GOS (β-GOS-2) and 0.5% β-GOS (β-GOS-5), ad 
libitum, throughout the experimental period of 35 days. 
The birds were vaccinated against Newcastle disease virus (NDV) and infectious 
bursal disease virus (IBDV). Live attenuated NDV vaccine (Ceva-Phylaxia, Budapest, 
Hungary) was given intraocularly on day 4 and repeated on day 20 in drinking water. 
Similarly, live intermediate strain IBDV vaccine (Lohman Animal Health GmbH, Cuxhaven, 
Germany) was given intraocularly on day 8 and booster of live attenuated IBDV vaccine was 
given on day 24 in drinking water. 
3.2.2. Growth Performance and Feed Conversion Efficiency 
Body weights of birds in individual replicates and feed intake (feed offered – feed 
leftover) were measured, by weighing balance, on a weekly basis and mortality was recorded 
on a daily basis, and the data were used for calculation of feed conversion efficiency by 
dividing feed intake with body weight.  
3.2.3. Sampling Protocols 
At the end of the experimental period, 10 birds from each group (2 birds / replica) 
were stunned and slaughtered by exsanguination. Blood samples were collected in plane 
plastic test tubes and kept at 4°C for 4 hours. Blood samples were centrifuged at 4,000 rpm at 
4°C for 20 minutes in a temperature controlled centrifuge machine. The top clear layer of 
serum was harvested in aliquots using a micropipette and stored at -40°C for serum 
biochemical and NDV antibodies titer analysis. 
The birds were weighed and the abdominal cavity of each bird was exposed to collect 
viscera and caecal digesta. Viscera were weighed and lengths of some viscera were 
measured. Absolute weights of viscera were used to calculate relative weights. Caecal digesta 
were collected in sterile plastic air tight test tubes and immediately transferred to the 
laboratory for enumeration of cecal microbiota. 
3.2.4. Serum Biochemistry 
 Frozen serum samples were thawed at room temperature for determination of serum 
biochemical metabolites including glucose, total proteins, albumin, cholesterol, triglycerides, 
uric acid, liver enzymes including alanine aminotransferase and aspartate aminotransferase 
and thyroid hormones including tri-iodothyronine and thyroxine. Serum globulins were 
determined by subtracting albumin from total proteins. Serum metabolites and liver enzymes 
were determined using commercial kits (Randox, UK) and reactions were read by 
spectrophotometer, whereas, thyroid hormones were determined using commercial 
competitive ELISA kits (BioCheck, CA). Glucose test was based on “Glucose Oxidase-
Reaction”, total proteins on “Alkaline-Copper-Reaction”, albumin on “BromoCresol Green-
Reaction”, cholesterol on “Cholesterol Oxidase-Reaction”, triglycerides on “LPL-Reaction” 
and uric acid on “ADPS Peroxidase-Reaction” (Young 2001). 
3.2.5. Caecal Microbial Populations 
 Caecal digesta collected from two birds in each replica was pooled to get a single 
sample. After pooling, five samples per treatment were obtained for enumeration of different 
microbial populations including coliforms, Clostridia spp. and Lactobacilli spp. using 
conventional plate culturing method. 
 Bacterial specific growth media were prepared by dissolving, under continuous stirrer 
at 40°C on temperature control magnetic hot plate, in distilled water. All media were 
autoclaved and then 20 mL of medium was poured into a sterile glass petriplate. The medium 
was allowed to solidify at room temperature. After solidification of medium, all petriplates 
were incubated at 37°C, in a temperature control incubator, for overnight to confirm sterility 
of media. 
 One gram digesta from each sample was taken, homogenized and serially diluted (10-
folds) in sterile saline solution. Hundred microliters diluted samples were inoculated and 
spread on bacterial specific growth media in petriplates. Coliforms were grown on 
MacConkey’s agar at 37°C for 24 hours under aerobic conditions. Clostridia spp. were grown 
on Reinforced Clostridial agar at 37°C for 24 hours under 5% CO2 conditions. Lactobacilli 
spp., being strict anaerobe, were grown on de Man, Rogossa and Sharpe (MRS) agar at 37°C 
for 48 hours under strict anaerobic conditions induced in anaerobic jars by anaerobic sachets 
(Oxoid, UK). All samples were run in triplicate and average values of colony forming units 
(CFU/g wet digesta) were used in statistical analysis, after log10 transformation. 
3.2.6. Immunity 
3.2.6.1. Humoral Immunity 
Antibody titers against NDV were used to determine humoral immunity. Antibody 
titers were determined by employing haemagglutination inhibition (HI) test (Brugh and 
Beard 1980). The HI test was conducted using haemagglutination of chicken red blood cells 
(CRBC). Chicken red blood cells were obtained from healthy chicken. For this purpose, 
blood was collected in heparinized vaccutainer using sterile needle. Blood was centrifuged at 
4,000 rpm for 20 minutes. Upper layer of plasma and middle buffy coat were removed and 
CRBC were washed thrice with normal saline by centrifugation. Washed CRBC were diluted 
with saline solution to prepare 1% CRBC suspension. The 1% CRBC suspension was used to 
determine 4 haemagglutination (HA) units of antigen as well as antibody titers against NDV. 
Four HA units of antigen were determined by dispensing 25 µL of NDV antigen, in 96 well 
round bottom microplate, 2-fold serially diluting with equal volume of saline solution and 
agglutination of CRBC. Highest dilution of NDV antigen exhibiting agglutination of CRBC 
was used to calculate 4 HA units. 
The HI test was performed by 2-fold serial dilution of 25 µL serum with equal volume 
of saline solution up to 11th well of 96 well microplate. Thereafter, same volume of 4 HA 
antigen was added to each well including well 12 of same row. Microplate was incubated at 
37°C for 30 minutes. After incubation, 25 µL CRBC (1%) was added to each well, 
microplate was shaken and again incubated 37°C for 30 minutes. Clear and sharp button 
formation of CRBC at the bottom of well indicates positive result i.e., HI. Well 12 served as a 
negative control. 
3.2.6.2. Cell Mediated Immunity 
 Cell mediated immunity (CMI) was determined by employing dermis delayed type 
hypersensitivity (DHT) reaction (Tiwary and Goel 1985). This is simple, cheaper and 
authentic technique to determine the overall effects of treatment on CMI in studied subjects 
and still used in modern trials. For this purpose, 1% solution of 2, 4-dinitrochlorobenzene 
(DNCB) was prepared in acetone. Two birds from each replicate were selected and sensitized 
with 250 µL of 1% DNCB solution. Breast skin of each bird was gently defeathered and 2 
cm2 area was marked. Solution of DNCB was dribbled slowly on marked area and dried with 
continuous air blow. Thigh skin of each sensitized bird was defeathered gently and 
challenged with same DNCB solution after 14 days of sensitization. Skin DHT was 
determined by measuring thigh skin thickness on day 0, 1st, 2nd and 3rd post-challenge dose. 
3.2.7. Statistical Analysis 
 Data were analyzed by using Statistical Package for Social Science (SPSS for 
Windows Version 13.0, SPSS Inc., Chicago, IL, USA). Data were subjected to Shapiro-Wilk 
test for confirmation of normal distribution. After confirmation, all data, except CMI data, 
were analyzed by one way analysis of variance (ANOVA). The CMI data were analyzed by 
repeated measuring ANOVA (Steel et al. 1997). In case of significant F-values, data were 
subjected to Tukey’s-HSD post-hoc test. Significance level was set at P < 0.05 and data were 
presented as means ± SE. 
3.3. RESULTS 
3.3.1. Performance 
 Body weights of birds supplemented with 0.2% and 0.5% of β-GOS (β-GOS-2 and β-
GOS-5, respectively) were higher (P < 0.05) compared with the control group (β-GOS-0) 
during the first two weeks, whereas, no differences in the body weights were observed 
between 0.1% β-GOS supplemented and (β-GOS-1) control groups (Table 3.1). During the 
third week, body weights of all the β-GOS supplemented birds were higher (P < 0.05) 
compared with the control birds. Body weights of 0.5% β-GOS supplemented birds were 
higher (P < 0.05) during the fourth and fifth weeks of experiment compared with other 
experimental groups. Feed intake in all the experimental groups remained the same and no 
significant differences were observed (Table 3.2). 
 Feed conversion efficiency remained the same among all experimental groups during 
the period of first two weeks. However, during the third week, feed conversion efficiency 
was better (P < 0.05) in all the β-GOS supplemented groups compared with the control group 
(Table 3.3). During the fourth and fifth weeks, feed conversion efficiency was better (P < 
0.05) in 0.5% β-GOS supplemented birds compared with other experimental birds. 
3.3.2. Organ Characteristics 
 Relative weights of liver and pancreas were higher (P < 0.05) in the 0.1% β-GOS 
supplemented birds compared with the control birds (Table 3.4). However, relative weights 
of heart, gizzard, spleen, small intestine and caecum, and relative lengths of small intestine 
and caecum remained unchanged among all the experimental groups.   
 
3.3.3. Serum Biochemistry 
 Concentrations of all serum biochemical metabolites, liver enzymes and thyroid 
hormones remained unchanged among all the experimental groups except cholesterol which 
was significantly higher in the 0.5% β-GOS supplemented birds compared with the control 
birds (Table 3.5). 
3.3.4. Cecal Microbiota 
 Coliforms and Clostridia spp. CFU in cecal digesta of all the experimental birds were 
remained unchanged (Figure 3.1 and 3.2). However, CFU/g digeta of Lactobacilli spp. in 
cecal digesta of the 0.2% and 0.5% β-GOS supplemented groups was higher (P < 0.05) 
compared with the control group (Figure 3.3). 
3.3.5. Immune Response 
 Supplementation of β-GOS at different inclusion concentrations did not affect the 
antibodies titres against the Newcastle disease viral vaccine compared to the non-
supplemented group (Figure 3.4). Cell mediated immune response was remained same in all 
the experimental groups for the period of first 48 hours post-challenging (Figure 3.5). 
However, cell mediated immune response was greater (P < 0.05) in next 24 hours (i.e., 72 
hours post-challenging) in all the β-GOS supplemented groups compared with the control 
group. 
3.4. DISCUSSION 
 Prebiotics being "non-digestible feed ingredients", improve the host health by 
favorably increasing the selective populations of beneficial microbes that harbor the 
gastrointestinal tract of birds (Hume 2011; Huyghebaert et al. 2011). However, desirable 
effects of prebiotics vary depending upon many crucial factors like the nature of the 
prebiotic, concentration, hygienic status of the feed and production unit as well as animal 
species (Ten Bruggencate et al. 2003; Verdonk et al. 2005; Biggs et al. 2007; Yang et al. 
2009). The present study is demonstrating the effects of different dietary concentrations of β-
galacto-oligosaccharides (β-GOS) on growth performance, feed conversion efficiency, organ 
development, serum biochemical metabolites, selected caecel microbial populations and 
immune response of broilers. 
 The results of the present study demonstrate that growth performance and feed 
conversion efficiency are affected by the β-GOS supplementation in a dose dependent 
manner. It is evident from results that the 0.5% β-GOS supplementation significantly 
improved the growth performance and feed conversion efficiency of broilers during the 
grower phase compared with the control and other supplemented groups. The 0.5% β-GOS 
supplementation, on an average, improves body weights by 11.4% and feed conversion 
efficiency by 13% during the fifth week of performance compared with the control group. 
Contrary to our findings, Jung et al. (2008) report that a dietary supplementation of 3% and 
12% GOS syrup, along with or without Bifidobacterium lactis supplementation, have no 
beneficial effects on growth performance and feed conversion efficiency in broilers. Similar 
finding on growth performance and feed conversion efficiency are also reported in GOS 
supplemented poultry (Biggs et al. 2007) and pigs (Mountzouris et al. 2006). Improved 
growth performance and feed conversion efficiency, in our trial, can be attributed to 
improved nutrient digestibility and bioavailability, short chain fatty acids production, shift in 
caecel microbial eco-physiology or immuno-modulation. Few trials are conducted to 
elucidate the effects of GOS supplementation on nutrients digestibility in different animal 
species with no positive effects on nutrient digestibility (Biggs et al. 2007; Kanakupt et al. 
2011). However, Biggs et al. (2007) report that dietary supplementation of high levels of 
oligosaccharides (0.8%) including oligofructose, short chain fructo-oligosaccharides and 
trans-galacto-oligosaccharides to poultry depress the metabolizable energy and amino acids 
digestibility, and, therefore, recommend low levels of oligosaccharides supplementation 
(0.4%). In vivo and in vitro studies demonstrate that GOS fermentation results in an increased 
short chain fatty acids production (Tzortzis et al. 2005; Ben et al. 2008; Kanakupt et al. 2011; 
Cardelle-Cobas et al. 2012) that can favorably improve the growth performance and feed 
conversion efficiency in supplemented subjects. The differences in the results of our studies 
compared to the previous studies indicate the significance of origin of β-GOS. For instance, 
β-GOS used in Jung et al. (2008) experiment was prepared by transgalactosylation of lactose 
by β-galactosidase of recombinant Pichia pastoris X-33. 
Results of organ characteristics reveal that 0.1% β-GOS supplementation increased 
the relative weights of liver and pancreas compared with the control group. The liver is of 
prime importance in supplying nutrients and energy metabolites to the body organs (Zuidhof 
et al. 2006) and, therefore, an increase in liver weight can be related to improved growth 
performance. Likewise, an increase in pancreas weight is also related with increased 
enzymatic activities and secretions (Nahas and Lefrancois 2001) that can result in improved 
feed digestibility and ultimately improved growth performance. However, no difference in 
growth performance and feed conversion efficiency is observed in the 0.1% β-GOS 
supplemented group compared with the control group. Therefore, no relation can be depicted 
between liver and pancreas weights with growth performance. 
 Gut microbiota have significant effects on the nutrients digestibility, bioavailability 
and therefore on overall host response and development (Rehman et al. 2008). It is being 
influenced by number of variables like diet composition and type, dietary supplementations 
including prebiotics, probiotics, essential oils and organic acids (Klaenhammer 2000; 
Peñalver et al. 2005; Rehman et al. 2008; Goodarzi Boroojeni et al. 2014). Our results reveal 
that caecal concentrations of Lactobacilli spp. are higher in the β-GOS supplemented groups 
compared with the control group. Many in vivo and in vitro studies demonstrate the 
lactobacillogenic effects of GOS in different animal species as well as human beings 
(Smiricky-Tjardes et al. 2003; Tzortzis et al. 2005; Ben et al. 2008; Jung et al. 2008; 
Macfarlane et al. 2008; Cardelle-Cobas et al. 2012). Our findings in combination with 
abovementioned trials demonstrate that GOS supplementation has lactobacillogenic effects. 
Beneficial attributes of Lactobacilli are well documented in the literature and include 
maintenance of gastrointestinal mucosal barrier (Yan and Polk 2010), bacteriocin production 
(Mazmanian et al. 2008), immune-modulation (Huang et al. 2004; Koenen et al. 2004) and 
growth suppression or competitive exclusion of intestinal pathogens (Higgins et al. 2007) 
which in single or in combination can improve the growth performance and feed conversion 
efficiency of host. In addition to indirect lactobacillogenic effects, the β-GOS has been 
reported to inhibit the attachment of different pathogens including Escherichia coli and 
Salmonella enterica serovar Typhimurium under in vitro conditions ["HT-29 epithelial cell 
line" (Tzortzis et al. 2005)] and in vivo conditions ["murine oral challenge model" (Searle et 
al. 2009)]. This property of β-GOS has been attributed to α-anomeric configured 
oligosaccharides. 
 Dietary supplementation of 0.1% β-GOS increased cell mediated immunity compared 
with the control group, whereas, high β-GOS supplementation (0.2% and 0.5%) does not 
affected cell mediated immunity in the current study. Several studies have shown that GOS 
supplementation enhances delayed-type hypersensitivity response in murine influenza 
vaccination model (Vos et al. 2006), natural killer cells activity and anti-inflammatory 
cytokines in human beings (Vulevic et al. 2008) and mice (Gopalakrishnan et al. 2012), and 
decreases pro-inflammatory cytokines production in humans (Vulevic et al. 2008). One in 
vitro study has shown that β-GOS partially inhibits TNF-α mediated NF-κB translocation 
and, therefore, reduces production of pro-inflammatory cytokines (Dubert-Ferrandon et al. 
2008). 
 It can be concluded that β-GOS has a potential to improve growth performance and 
feed conversion efficiency in broilers that seems to be linked with fermentation of β-GOS by 
Lactobacilli and immuno-modulation. However, studies are warranted to confirm the effects 
of β-GOS supplementation on nutrients digestibility and short chain fatty acids in poultry. 
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 Table 3.1. Response of different dietary concentrations of β-galacto-oligosaccharides on 
body weights (g ± SE) of broilers 
Period Treatments 
β-GOS-0 β-GOS-1 β-GOS-2 β-GOS-5 
1st Week 153 ± 1.7c 158 ± 3.0bc 164 ± 1.3ab 170 ± 1.1a 
2nd Week 356 ± 2.4c 371 ± 5.2bc 384 ± 4.1ab 390 ± 3.8a 
3rd Week 725 ± 6.9b 753 ± 2.7a 756 ± 2.7a 761 ± 1.1a 
4th Week 1098 ± 19.0b 1121 ± 9.6b 1143 ± 9.2b 1227 ± 19.3a 
5th Week 1514 ± 51.1b 1516 ± 18.0b 1574 ± 27.0b 1722 ± 18.4a 
Different superscriptsa-c in a column differed significantly (P < 0.05) 
 
 
 
Table 3.2. Response of different dietary concentrations of β-galacto-oligosaccharides on 
feed intake (g ± SE) of broilers 
Period Treatments 
β-GOS-0 β-GOS-1 β-GOS-2 β-GOS-5 
1st Week 135 ± 3.2 135 ± 4.4 133 ± 4.6 133 ± 5.2 
2nd Week 426 ± 9.3 424 ± 9.1 430 ± 6.9 428 ± 4.6 
3rd Week 913 ± 6.4 911 ± 4.9 908 ± 5.3 912 ± 6.0 
4th Week 1562 ± 17.6 1571 ± 11.8 1578 ± 6.8 1570 ± 9.1 
5th Week 2453 ± 17.6 2443 ± 21.3 2447 ± 16.2 2439 ± 15.9 
 Table 3.3. Response of different dietary concentrations of β-galacto-oligosaccharides on 
feed conversion efficiency (ratio ± SE) of broilers 
Period Treatments 
β-GOS-0 β-GOS-1 β-GOS-2 β-GOS-5 
1st Week 0.88 ± 0.03a 0.85 ± 0.03a 0.81 ± 0.03a 0.78 ± 0.03a 
2nd Week 1.19 ± 0.03a 1.14 ± 0.04a 1.12 ± 0.03a 1.10 ± 0.02a 
3rd Week 1.26 ± 0.02a 1.21 ± 0.01b 1.20 ± 0.01b 1.20 ± 0.01b 
4th Week 1.43 ± 0.04a 1.40 ± 0.02a 1.38 ± 0.01a 1.28 ± 0.02b 
5th Week 1.63 ± 0.05a 1.61 ± 0.03a 1.55 ± 0.03a 1.42 ± 0.01b 
Different superscriptsa-b in a column differed significantly (P < 0.05) 
 Table 3.4. Response of different dietary concentrations of β-galacto-oligosaccharides on 
relative organs characteristics (ratio ± SE) of broilers 
Organs Treatments 
β-GOS-0 β-GOS-1 β-GOS-2 β-GOS-5 
Weights 
Heart 0.45 ± 0.01a 0.49 ± 0.02a 0.48 ± 0.02a 0.49 ± 0.02a 
Gizzard 1.71 ± 0.04a 1.84 ± 0.08a 1.76 ± 0.03a 1.73 ± 0.09a 
Liver 2.45 ± 0.09b 2.80 ± 0.09a 2.61 ± 0.08ab 2.35 ± 0.08b 
Pancreas 0.22 ± 0.01b 0.28 ± 0.02a 0.23 ± 0.01b 0.23 ± 0.01b 
Spleen 0.11 ± 0.01a 0.16 ± 0.02a 0.13 ± 0.02a 0.12 ± 0.01a 
Small Intestine 2.15 ± 0.10a 2.32 ± 0.10a 2.15 ± 0.06a 2.31 ± 0.09a 
Caecum (Filled) 0.52 ± 0.04a 0.49 ± 0.04a 0.52 ± 0.04a 0.45 ± 0.04a 
Caecum 
(Empty) 
0.28 ± 0.01a 0.30 ± 0.02a 0.32 ± 0.01a 0.28 ± 0.01a 
Lengths 
Small Intestine 3.16 ± 0.07a 3.45 ± 0.07a 3.18 ± 0.09a 3.24 ± 0.12a 
Caecum 0.64 ± 0.02a 0.64 ± 0.04a 0.64 ±0.02a 0.64 ± 0.02a 
Different superscriptsa-b in a column differed significantly (P < 0.05) 
 Table 3.5. Response of different dietary concentrations of β-galacto-oligosaccharides on 
serum biochemical metabolites of broilers  
Parameters Treatments 
β-GOS-0 β-GOS-1 β-GOS-2 β-GOS-5 
Glucose (mg/dL) 273.87 ± 10.75a 246.55 ± 7.03a 277.54 ± 10.40a 267.61 ± 8.84a 
Total Proteins (g/dL) 3.16 ± 0.26a 3.69 ± 0.27a 3.41 ± 0.35a 3.79 ± 0.20a 
Albumin (g/dL) 1.83 ± 0.05a 1.92 ± 0.04a 1.95 ± 0.06a 1.92 ± 0.04a 
Globulins (g/dL) 1.37 ± 0.11a 1.77 ± 0.10a 1.14 ± 0.13a 1.83 ± 0.17a 
Cholesterol (mmol/L) 2.11 ± 0.24b 2.49 ± 0.30ab 2.88 ± 0.19ab 3.42 ± 0.28a 
Triglycerides 
(mmol/L) 
0.91 ± 0.07a 1.11 ± 0.14a 1.11 ± 0.09a 1.26 ± 0.08a 
Uric acid (µmol/L) 460.48 ± 35.10a 454.44 ± 46.08 a 489.80 ± 35.18a 483.22 ± 37.52a 
Aspartate 
Aminotransferase 
(U/L) 
138.98 ± 22.00a 122.48 ± 16.26a 129.87 ± 13.79a 140.34 ± 12.75a 
Alanine 
Aminotransferase 
(U/L) 
14.47 ± 3.10a 13.10 ± 2.42a 10.23 ± 1.35a 11.24 ± 2.02a 
Tri-iodothyronine 
(ng/dL) 
184.33 ± 22.41a 176.67 ± 8.82a 176.33 ± 11.89a 160.33 ± 11.29 a 
Thyroxine (µg/dL) 1.63 ± 0.26a 2.03 ± 0.63a 1.77 ± 0.42a 1.34 ± 0.35a 
Different superscriptsa-b in a column differed significantly (P < 0.05) 
  
 
 
 Different superscriptsa-b on bars differed significantly (P < 0.05) 
 
 
 Different superscriptsa-b on lines differed significantly (P < 0.05) 
CHAPTER 4 
EXPERIMENT 2 
 
Comparison of Two Different Types of Benzoic Acid Supplementation on Growth 
Performance, Microbial Metabolites, Microbial Populations and Molecular Microbial 
Ecology in Broilers 
4.1. INTRODUCTION 
Profitability in poultry production systems depends upon a number of decisive factors 
like maximum nutrient digestibility, absorption, availability and conversion into valuable end 
products. In this regard, the gastrointestinal tract (GIT) health is a prime focus of interest 
because any impairment in gastrointestinal functioning and gut microbial dysbiosis can 
adversely affect the digestion, metabolism and availability of nutrients. These factors, 
altogether, result in poor growth performance, impaired feed efficiency and high mortality in 
birds (Dibner and Richards 2005). Gastrointestinal microbes, ubiquitous and heterogenous, 
play complex and important role in nutrition, metabolism, growth and health of growing 
animals (Dinber and Buttin 2002; Torok et al. 2011), the nutrients in the GIT are 
competitively partitioned between host-bird and gut microflora for energy. Therefore, more 
partitioning of nutrients towards host-birds is another desirable factor that can positively 
influence the performance and health of growing birds. This is managed, in part, by 
fortification of poultry feed with sub-therapeutic levels of antibiotics (Huyghebaert et al. 
2011). However, following a ban imposed by the European Commission (2006) on in-feed 
antibiotics as growth promoters, investigators are seeking alternatives. A number of feed 
additives, termed as eubiotics, including prebiotics, probiotics, phytobiotics, essential oils, 
enzymes and organic acids have proposed to improve nutrients digestibility, utilization, gut 
health and gut microbial equilibrium, which will eventually improve overall performance of 
the birds (Wenk 2002). 
Organic acids and salts of organic acids are commonly used as feed preservative (Jay 
1992) and feed additives (Huyghebaert et al. 2011) to improve the feed hygiene and the 
performance of the animals, respectively. These weak acids confer beneficial effects by 
reducing total gut microbial load, lowering digesta pH, improving microbial phytase, and 
increasing pancreatic and bile secretion, which ultimately results in improved nutrient 
digestibility and utilization (Thompson and Hinton 1997; Partanen and Mroz 1999; Dibner 
and Buttin 2002; Ricke 2003; Van Immerseel et al. 2006). Being antimicrobials, activities of 
organic acids differ from each other and are influenced by concentration and pH (Chaveerach 
et al. 2002), chemical nature, animal species and feed buffering capacity (Thompson and 
Hinton 1997). For instance, lactic acid is antibacterial, sorbic acid is antimold, formic and 
propionic acids are antifungal and antibacterial (Partanen and Mroz 1999; Dibner and Buttin 
2002) and benzoic acid is antibacterial and antifungal (Friedman et al. 2003; Torrallardona et 
al. 2007). Gut microbiota respond to organic acid cocktails by showing a shift towards more 
distinct and homogenous populations along with an increased colonization of the chick ileum 
with Lactobacilli (Nava et al. 2009). Organic acids in poultry nutrition include benzoic acid, 
citric acid, formic acid, fumaric acid, gluconic acid, lactic acid, propionic acid and their 
cocktails (Rafacz-Livingston et al. 2005; Hernandez et al. 2006; Sacakli et al. 2006; Józefiak 
et al. 2007; 2010; Liem et al. 2008; Pirgozliev et al. 2008; Józefiak et al. 2010; Goodarzi 
Boroojeni et al. 2014a). 
Benzoic acid (BA), a simple organic acid, is common in pig nutrition and has been 
shown to improve weight gain, feed intake, feed efficiency and to reduce acetic acid 
concentrations in the duodenum with no effect on nutrient utilization (Kluge et al. 2006; 
Guggenbuhl et al. 2007). Studies based on in vitro and in vivo trials demonstrate that BA 
reduces coliforms and lactic acid bacteria (Knarreborg et al. 2002), caecal microbiota in pigs 
(Biagi and Piva 2005), E. coli in weaning piglets (Torrallardona et al. 2007), and gram-
negative bacteria in pigs (Kluge et al. 2006). Few studies demonstrate the effect of BA 
supplementation on growth performance, feed efficiency, GIT microbiota and short chain 
fatty acids in poultry (Józefiak et al. 2007, 2010). Higher concentrations of BA (0.5-0.75%) 
depress the growth performance, feed efficiency and lower the crop and the ileal coliforms, 
whereas increases in caecal lactic acid bacteria are observed (Józefiak et al. 2007). 
Supplementation of 0.1% BA improves growth performance and feed efficiency during the 
first two weeks of age. However, 0.2% BA supplementation depresses growth performance in 
broilers (Józefiak et al. 2010). Lactic acid bacteria concentration increases in ileal digesta 
after administration of 0.2% BA, whereas, 0.1-0.2% BA supplementation decreases coliforms 
in ileal digesta. In addition to these effects, BA supplementation also changes the profile of 
various short chain fatty acids in different GIT segments of broilers (Józefiak et al. 2010). 
In conclusion, dietary supplementation of BA, in different animal species, has shown 
dose dependent responses on growth performance, feed efficiency, GIT microbial ecology as 
well as microbial metabolites. However, BA is corrosive and continuous exposure can induce 
urticaria, asthma or rhinitis in human beings (Anderson 1996; Coverly et al. 1998). 
Moreover, organic acids are rapidly absorbed while leaving low concentrations in the lower 
GIT for action. Therefore, in a user friendly formulation of BA (Provenia, Novus 
Deutschland GmbH, Gudensberg, Germany), BA is embedded in a fatty acid matrix, 
formulated with the concept that it may improve BA functioning in the GIT compared with 
free BA, due to slow release and absorption. The aim of the present study was to compare the 
effects of free BA and slow releasing BA supplementation on growth performance, feed 
efficiency, microbial metabolites, microbial populations and molecular microbial ecology in 
the GIT of broilers. In depth understanding of host and GIT microbial interaction and 
relationship are important to elucidate the mechanism of action of feed additives. These 
objectives can be achieved by using modern finger printing techniques like PCR coupled 
denaturing gradient electrophoresis (DGGE) and quantification techniques like real time-
PCR. 
4.2. MATERIALS AND METHODS 
4.2.1. Experimental Design 
A total of 120, day-old male broiler chicks (Cobb), were purchased from a 
commercial hatchery (Cobb Germany Avimex GmbH, Wiesenena-Wiedemar) and reared in 
an environmentally controlled house (Institute of Animal Nutrition, Free University Berlin, 
Germany) bedded with softwood shaving. The birds were equally divided into three treatment 
groups (n = 40/group) with eight replicas (n = 5) in each treatment group. During the 
brooding period in the first and second weeks, the temperature was kept at 34 ± 0.5°C by 
infrared heaters and relative humidity was maintained at 60 ± 5.5%. Temperature was 
decreased 0.5°C on a daily basis and maintained at 22°C for the rest of the experimental 
period, whereas, relative humidity was kept constant at 60 ± 5.5%. Lighting program 
included 24 hours light from day 1 to 3, 23 hours light and an hour darkness from day 4 to 7 
and 18 hours light and 6 hours darkness from day 8 onward. The birds were fed on a maize 
based basal diet (Annexure; Table II), formulated free of antimicrobials and coccidiostats to 
meet or exceed recommendations of the "Society of Nutrition Physiology" (GfE 1999), or 
same diet supplemented with free benzoic acid (FBA) or slow releasing benzoic acid (SBA). 
Three experimental diets were prepared by mixing 0%, 0.096% FBA and 0.2% SBA, 
and fed to the experimental birds. Birds in the control (CON) group were provided basal diet 
(0% BA) and birds in other two groups were provided the same basal diets supplemented 
with 0.096% FBA and 0.2% SBA, ad libitum, throughout the experimental period of 35 days. 
All the experimental protocols were approved by the "State Office of Health and Social 
Affairs Berlin" (LAGeSo Reg. No. 0023/11). 
4.2.2. Growth Performance and Feed Conversion Efficiency 
Body weights and feed intake of the birds were measured on a weekly basis and 
mortality was recorded on a daily basis, and the data were used for calculation of feed 
conversion efficiency that was calculated by dividing feed intake with body weight. 
4.2.3. Sampling Protocols 
At the end of the experimental period, all birds were stunned and killed by 
exsanguination. The abdominal cavity of each bird was exposed to collect digesta from crop, 
proventriculus, gizzard, proximal small intestine, ileum and caecum for determination of pH, 
short chain fatty acids (SCFA), lactate, benzoic acid, bacterial populations and molecular 
microbial ecology. Digesta of each replica was pooled and collected in sterile plastic air tight 
test tubes and stored at -80°C for analysis. 
4.2.4. Digesta Short Chain Fatty Acids 
Digesta were thawed on ice and after complete thawing, digesta were thoroughly 
homogenized by vortexing. The SCFA were analyzed by using gas chromatography (Schäfer 
1995). A total of 0.5 g digesta was weighed and diluted with 100 mM 3-(N-morpholino) 
propane sulfonic acid buffer having pH 7.5 (1:2). The digesta was thoroughly homogenized 
for 1 minute, thereafter, incubated on ice for 10 minutes and then centrifuged for 20 minutes 
at 20,000 x g at 4°C. After centrifugation, 100 μL supernatant was filtered through 0.2 µm 
sterile cellulose acetate syringe filter and stored in air tight glass tube with rubber septum at 
top, whereas, rest of the supernatant was processed for lactate estimation.  
As an internal standard, 900 µL of 0.5 mmol/L caproic acid (Sigma-Aldrich, 
Deisenhofen, Germany) was mixed with 100 µL of sample supernatant and 1 µL of prepared 
sample was injected in a gas chromatograph (Agilent Technologies, model 6890N, Santa 
Clara, CA), coupled with an auto-sampler (G2614A) and an auto-injector (G2613A), 
containing HP-INNOWAX polyethylene glycol column (Agilent Technologies, model 
19095N-123; 30 meters in length, 5.3 mm internal diameter and 1 µm film thickness). Th 
initial temperature of the oven was set at 70°C, injector at 230°C and flame-ionization-
detector at 250°C. Hydrogen gas was used as a carrier medium with a flow rate of 30 mL per 
minute. 
4.2.5. Digesta Lactate 
The supernatant, isolated for lactate determination, was mixed with 50 μL of Carrez-I 
and Carrez-II solutions, containing potassium hexacyanoferrate (II) trihydrate and zinc 
sulfate heptahydrate, respectively. A total of 200 µL supernatant was filled up to 1 mL with 
0.5 mM copper-II-sulfate solution and injected in high performance liquid chromatograph 
(Agilent Technologies, model 1100, Santa Clara, CA) containing Phenomenex Chirex 3126 
(d)-penicillamine (150 × 4, 6-mm) column and Phenomenex C18 pre-column (4.0 L × 2.0 ID 
mm) for determination of L- and D-lactate. Temperature of the HPLC column was kept at 
35°C and lactate was detected at 253 nm. 
4.2.6. Feed and Digesta Benzoic Acid 
A total of 5 g of feed or digesta was mixed with 30 mL of double distilled water and 
vortexed for 15-30 seconds. Thereafter, the vortexed sample was added with 60 mL of o-
phosphoric acid and again vortexed. The sample was then centrifuged and the isolated 
supernatant was filtered through 0.2 µm sterile cellulose acetate syringe filter. A total of 5 µL 
supernatant was injected in high performance liquid chromatograph (Agilent Technologies, 
model 1100, Santa Clara, CA) containing Agilent Poroshell 120 EC-C18 column (4.6 × 100 
mm) for determination of benzoic acid. Temperature of the HPLC column was kept at 20°C 
and benzoic acid was detected at 243 nm. 
4.2.7. Digesta pH 
 Digesta samples were thawed on ice and after complete thawing, digesta were 
thoroughly homogenized by vortexing. The glass electrode of a pH meter was dipped in the 
digesta and the pH value was recorded after stabilization of reading. The glass electrode was 
cleaned, rinsed with double distilled water and dried before subsequent analyses. 
4.2.8. Digesta Microbial Populations 
4.2.8.1. Extraction and Purification of Digesta Microbial DNA 
 Microbial DNA from digesta samples was extracted and purified using mini-fecal 
DNA extraction kit (Qiagen, Hilden, Germany). Centrifugation of samples were carried out at 
20,000 x g and DNA extraction steps were performed at room temperature, otherwise 
specified in protocol. All the procedures were performed using sterile equipment and 
environmental conditions. This procedure yields 15-60 µg DNA (75-300 ng/µL).  
 Briefly, 200 mg digesta was weighed into a 2 mL micro-centrifuge tube and 1.8 mL 
“ASL buffer” was added to each sample, vortexed for 1 minute and heated for 10 minutes at 
90°C in a thermal block. After heating, sample was vortexed for 15 seconds and centrifuged 
for 1 minute to pellet the digesta particles. Supernatant (1.2 mL) was pipetted into a new 2 
mL micro-centrifuge tube; “inhibitEX” tablet was added into each sample and vortexed 
immediately for 1 minute. The suspension was incubated for 1 minute and then centrifuged 
for 3 minutes to pellet inhibitors, bound to tablet matrix.  
The supernatant (350 µL) was pipetted into new 2 mL micro-centrifuge tube 
containing 15 µL of proteinase K, mixed and 350 µL of “AL buffer” was added. The whole 
suspension was vortexed for another 15 seconds and incubated for 10 minutes at 70°C in a 
thermal block. Thereafter, 350 µL of ethanol (96-100%) was added to the suspension and 
vortexed. After vortexing, 650 µL of sample was transferred into another 2 mL micro-
centrifuge tube having “QIAamp spin column” and centrifuged for 1 minute. The spin 
column was transferred into another 2 mL micro-centrifuge tube and 500 µL of “AW1 
buffer” was added and centrifuged for 1 minute. The spin column was again transferred into 
another 2 mL micro-centrifuge tube and 500 µL of “AW2 buffer” was added and centrifuged 
for 3 minutes. 
After centrifugation, the column was transferred into 1.5 mL micro-centrifuge tube 
and 200 µL of “AE buffer” was added, incubated for 1 minute and then centrifuged for 1 
minute. Spin column was discarded and filtrate containing DNA in 1.5 mL micro-centrifuge 
tube was stored at -20°C till analysis.     
4.2.8.2. Real Time Polymerase Chain Reaction for Microbiology 
 Real time polymerase chain reaction (q-PCR) quantification of different bacterial 
populations was conducted using 2x SYBR-green master-mix (Stratagene, Amsterdam, The 
Netherlands) on q-PCR machine (MX3005-P, Stratagene). All the reactions were carried out 
in a final volume of 25 µL. The reaction mixture was prepared by mixing appropriate 
quantities of SYBR-green master-mix, PCR-grade water, genus or species specific forward 
(10 µM) and reverse primers (10 µM), and 1 µL template DNA. Primers were procured from 
the MWG Biotech (Straubing, Germany). 
The q-PCR program was split into three segments; segment-I included 1 cycle (15 
minutes at 95°C to activate Taq-Polymerase), segment-II included forty cycles (15 seconds at 
95°C to denature DNA strands, 1 minute at primer specific annealing temperature and 1 
minute at 72°C for elongation) and segment-III included one cycle (temperature ramping 
down from 95°C to 55°C in 1 minute and temperature ramping up from 55°C (30 seconds 
delay) to 95°C (30 seconds delay) for melting curve analysis. 
Bacterial quantification was carried out by amplification of 16S ribosomal DNA gene 
except Enterobacteriaceae, which was quantified by ribosomal polymerase β-subunit (rpo-B) 
gene amplification (Annexure; Table III). 
4.2.9. Digesta Molecular Microbial Ecology 
4.2.9.1. Polymerase Chain Reaction 
 DNA was amplified by PCR for determination of molecular microbial ecology of ileal 
and cecal digesta. The reference standard sample, in addition to samples, was also amplified 
by PCR. The reference standard sample was prepared by mixing equal quantities of DNA 
from each representative sample. The PCR amplification was conducted using HotStar-Taq 
master-mix (Qiagen, Hilden, Germany) on T1 PCR machine (Biometra, Gӧttingen, 
Germany). All the reactions were carried out in a final volume of 25 µL. The reaction 
mixture was prepared by mixing appropriate quantities of HotStar-Taq master-mix, PCR-
grade water, universal bacterial rpo-B forward (10 µM) and reverse primers (10 µM), and 1 
µL template DNA. 
 The PCR amplification program was split into different segments as follow: segment-
I included 1 cycle (15 minutes at 95°C to activate Taq-Polymerase), segment-II included 15 
cycles (20 seconds at 95°C to denature DNA strands, 45 seconds at 57°C (-0.5°C/cycle) and 
45 seconds at 72°C for elongation), segment-III included 15 cycles (20 seconds at 95°C to 
denature DNA strands, 45 seconds at 49°C and 45 seconds at 72°C for elongation) and 
segment-IV included one cycle (10 minutes at 72°C for elongation and final hold at 4°C). 
 The primer sequences, obtained from literature, are given in Annexure; Table III. 
Samples after amplification were either stored at -20°C till analysis or immediately subjected 
to molecular microbial ecology analysis. 
4.2.9.2. Denaturing Gradient Gel Electrophoresis 
 The PCR amplified frozen samples were thawed at room temperature and subjected to 
molecular microbial ecology analysis by INGENYphorU vertical denaturing gradient gel 
electrophoresis (DGGE) apparatus (Ingeny International, Goes, The Netherlands). The 
amplified DNA samples (15 µL) were transferred into 96-well microtiter plate containing 
DNA loading buffer (5 µL) and mixed thoroughly. The DGGE tank was filled with 16 liters 
of 0.5x Tris-Acetate-EDTA (TAE) buffer and temperature was set at 60°C. Gel casting plates 
were coated with gelbond film and fixed in gel casting stand. Thereafter, 30-55% urea-
denaturing gradient gel was prepared by mixing 0% and 100% urea-denaturing 
polyacrylamide in appropriate ratio, while using gradient mixer. The gel was then layered 
with 0% urea-denaturing polyacrylamide, welled with 32-wells comb and allowed to solidify 
for at least an hour, while covered under towel. 
After solidification, 32-wells comb was removed and gel plates, fitted in gal casting 
apparatus, were placed in DGGE tank containing TAE buffer. The wells in the gels were 
filled up with TAE buffer and then loaded with 15 µL of DNA samples. The process of 
electrophoresis was started with 100 volts (33-40 mA) for first 15 minutes and then decreased 
to 70 volts (33-40 mA) for 17 hours at 60°C. 
After completion of electrophoresis, gelbond containing gel was removed from gel 
plates and processed for gel development. Gel was rinsed with double distilled water for 5 
minutes in tray shaker and then placed in 1x Carins solution for 3 minutes. The gel was then 
placed in silver stain solution for 10 minutes on shaker and washed with double distilled 
water for 2 minutes. After washing, gel was placed in developer solution for 45 minutes 
under continuous and uniform shaking. The developed gel was then placed again in 1x Carins 
solution for 5 minutes and rinsed with double distilled water for 2 minutes. Thereafter, gel 
was placed in storage solution for 7 minutes under continuous shaking and then covered with 
cellophane sheet, and allowed to dry at room temperature for 24 hours. Compositions of all 
the solutions, used for DGGE, are mentioned in the Annexure. 
The gel, in this form, was stored till analysis. At the time of analysis, gel was scanned 
by scanner and imported to Phoretix-1D (Version 5.1, Phoretix International Limited, 
Newcastle upon Tyne, UK) computer software for analysis of banding patterns. Thereafter, 
different microbial diversity indices including richness, evenness, the Shannon index, the 
Simpson index, the Sorensen index, the Morisita index and the Renkonen index were 
calculated. 
4.2.10. Statistical Analysis 
 Data were analyzed by using Statistical Package for Social Science (SPSS for 
Windows Version 13.0, SPSS Inc., Chicago, IL, USA). Data were subjected to Shapiro-Wilk 
test for confirmation of normal distribution. After confirmation, all data, except Morisita 
index and Renkonen index, were analyzed by one way-ANOVA (Steel et al. 1997). In case of 
significant F-values, data were subjected to Tukey’s-HSD post-hoc test. Significance level 
was set at P < 0.05 and data were presented as means ± SE. The Morisita and the Renkonen 
indices of microbial diversity were considered different below value 0.5. 
 
 
 
4.3. RESULTS 
4.3.1. Performance 
 Body weights of birds supplemented with FBA and SBA remained the same during 
the entire experimental period, except during the second week, compared to the control group 
(Table 4.1). During the second week, body weights of SBA supplemented birds were lower 
(P < 0.05) compared with the control and FBA groups. Likewise, feed intake was lower in the 
SBA supplemented birds compared with the control group (Table 4.2). However, feed intake 
remained same among all the experimental groups during other weeks. Feed conversion 
efficiency in all the experimental groups remained same and no significant differences were 
observed during the entire experimental period (Table 4.3). 
4.3.2. Digesta Lactate and Short Chain Fatty Acids 
4.3.2.1. Crop 
 Total short chain fatty acids concentrations remained the same among all the 
treatments groups (Table 4.4). Concentration of L-lactate was higher (P < 0.05) in the SBA 
group compared with the control group, whereas no significant difference was observed in 
the L-lactate concentration between FBA and control groups. Concentration of D-lactate was 
higher (P < 0.05) in both the supplemented groups compared with the control group. 
Concentration of i-valeric acid was higher (P < 0.05) in the SBA group compared with the 
FBA and control groups, whereas no significant difference was observed in i-valeric acid 
concentration between FBA and control groups. n-valeric acid was not detected in the control 
group, however, BA supplementation produced small amounts of n-valeric acid and highest 
concentration was observed in the SBA group. Concentrations of other short chain fatty acids 
were remained same among all the treatment groups (Table 4.5). 
4.3.2.2. Proventriculus 
 Total short chain fatty acids concentrations remained the same among all the 
treatments groups (Table 4.4). Concentrations of L-lactate and D-lactate as well as short 
chain fatty acids, except n-butyric acid, remained the same among all the experimental 
groups. Concentration of n-butyric acid was lower (P < 0.05) in the SBA group compared 
with the control group. However, no difference in n-butyric acid concentration was observed 
between FBA and control groups (Table 4.6). 
4.3.2.3. Gizzard 
  Total short chain fatty acids concentrations were higher (P < 0.05) in the FBA and 
the SBA groups compared with the control group (Table 4.4). Likewise, concentrations of L-
lactate, D-lactate and acetic acid were higher (P < 0.05) in the FBA and the SBA groups 
compared with the control group. However, concentration of n-butyric acid was lower (P < 
0.05) in the FBA group compared with the SBA and the control groups. Concentrations of 
other short chain fatty acids were remained same among all the experimental groups (Table 
4.7). 
4.3.2.4. Small Intestine 
 Total short chain fatty acids concentrations remained the same among all the 
treatments groups in proximal small intestine and ileum (Table 4.4). D-lactate concentration 
was higher (P < 0.05) in the FBA and SBA groups compared with the control group in the 
proximal small intestinal segment, whereas the concentrations of L-lactate and all short chain 
fatty acids remained the same among different treatments in proximal small intestine (Table 
4.8). Likewise, no differences were observed in lactate and short chain fatty acids 
concentrations among treatments in ileum (Table 4.9). 
 
4.3.2.5. Caecum 
 Total short chain fatty acids concentrations remained the same among all the 
treatment groups (Table 4.4). Either forms of lactate were absent in the caecal digesta. 
Concentrations of i-butyric acid and i-valeric acid were lower (P < 0.05) in the FBA and the 
SBA groups compared with the control group. However, n-valeric acid concentration was 
lower (P < 0.05) in the SBA group compared the control group, whereas no difference in n-
valeric acid concentration was observed between the FBA and the control groups. 
Concentrations of other short chain fatty acids were remained same among all the 
experimental groups (Table 4.10). 
4.3.3. Digesta Benzoic Acid and pH 
 The concentration of benzoic acid was higher (P < 0.05) in all the respective segments 
of the gastrointestinal tract in the FBA and the SBA groups compared with the control group 
(Figure 4.1 and 4.2). Digesta pH in all the respective segments of gastrointestinal tract 
remained the same among all the experimental groups (Figure 4.3 and 4.4). 
4.3.4. Digesta Microbiota 
4.3.4.1. Crop 
 Concentrations of Lactobacilli spp., E. coli/ Hafnia/ Shigella and Enterococci spp. 
remained the same among all the experimental groups (Table 4.11). 
4.3.4.2. Gizzard 
 Concentrations of Lactobacilli spp. were higher (P < 0.05) in the FBA and the SBA 
groups compared with the control group. L. johnsoni and L. reutri concentrations were higher 
(P < 0.05) in the SBA group compared with the control group, however, no difference was 
observed between the FBA and the control groups. Concentration of L. amylovorus was 
remained same among all the experimental groups (Table 4.12). 
4.3.4.3. Small Intestine 
 Concentrations of Lactobacilli spp., L. reutri, L. amylovorus and Enterococci spp. 
were higher (P < 0.05) in the FBA and the SBA groups compared with the control group in 
the proximal small intestine, whereas, concentration of L. johnsoni remained the same among 
all the treatment groups (Table 4.13). In the ileal digesta, concentrations of Lactobacilli spp., 
L. amylovorus and S. alactolyticus were higher (P < 0.05) in the SBA group compared with 
the control group, whereas, no differences in the concentrations of Lactobacilli spp. and L. 
amylovorus were observed between the FBA and the control groups. Concentration of L. 
johnsoni was higher (P < 0.05) in the FBA group compared with the control group, whereas, 
it was lower (P < 0.05) compared with the SBA group. L. reutri concentration was higher (P 
< 0.05) in both the BA supplemented groups compared with the control group. However, the 
concentrations of other studied bacteria were remained same among all the treatment groups 
in ileal digesta (Table 4.14). 
4.3.4.4. Caecum 
 Concentrations of all the studied bacteria remained unaffected by dietary 
supplementation of BA compared to the control group (Table 4.15). 
4.3.5. Digesta Molecular Microbial Ecology 
4.3.5.1. Ileum 
 Evenness of microbial ecology was higher (P < 0.05) in the FBA and the SBA groups 
compared with the control group, whereas, richness remained the same among all the 
experimental groups. Among different microbial diversity indices, significant differences 
were observed in the Sorensen index in the SBA group compared with the FBA and the 
control groups. However, the Shannon index and the Simpson index were not affected by 
supplementation of either types of BA (Table 4.16). The Renkonen index demonstrated a 
variation (< 0.5) in the microbial diversity between the control and the SBA groups. The 
Morisita index, on the other hand, did not show variation in the microbial diversity among 
different experimental groups (Figure 4.5). Dendrogram demonstrating the similarity of 
banding patterns has been shown in figure 4.7.      
4.3.5.2. Caecum  
 Richness, evenness and microbial diversity indices including the Shannon index, 
Simpson index and the Sorensen index were not affected by supplementation of BA 
compared with the control group (Table 4.17). Likewise, the Renkonen index and the 
Morisita index did not demonstrate variation in the microbial diversity among different 
experimental groups (Figure 4.6). Dendrogram demonstrating the similarity of banding 
patterns has been shown in figure 4.8.  
4.4. DISCUSSION 
Organic acids, salts of organic acids or their mixtures are commonly used as feed 
preservatives (Jay 1992; Polonen et al. 2000) and feed additives (Ricke 2003; Chaveerach et 
al. 2004; Kluge et al. 2006; Huyghebaert et al. 2011) to improve feed hygiene by blocking 
multiplication of pathogens and the performance of animals by modulating gut microbial 
activities and populations (Goodarzi Boroojeni et al. 2014a; Goodarzi Boroojeni et al. 
2014b), respectively. However, desirable effects of organic acids vary that depend upon 
many crucial factors like nature of organic acid, concentration, spectrum of antimicrobial 
activity, buffering capacity of the feed, hygienic status of the feed and production unit as well 
as animal species (Chaveerach et al. 2004; Dibner and Buttin 2002). Free forms of organic 
acids, added in the feed, are rapidly absorbed from the upper segments of the gut (Hume et al. 
1993; Thompson and Hinton 1997), leaving low concentrations to reach the distal segments 
of the gut. This issue is resolved by adopting different microencapsulation techniques that 
prevent dissociation of organic acids and help them to reach the distal segments of the gut 
and, therefore, make them able to modify the microbial metabolic activities and populations 
(Mroz et al. 2006; Hu and Guo 2007; Smulikowska et al. 2009). The present study compared 
the effects of free and slow releasing forms of benzoic acid (BA) on growth performance, 
feed conversion efficiency, gut microbial metabolites, microbial populations and molecular 
microbial ecology in broilers. 
The results of the present study demonstrated that growth performance and feed 
conversion efficiency are not affected by both forms of BA, except during the second week 
that is characterized by significantly reduced body weights and feed intake in the slow 
releasing BA (SBA) group. The study on BA supplementation in broilers demonstrates that 
concentrations higher than 0.25% compromised growth performance as well as feed 
conversion efficiency (Józefiak et al. 2007). In another broilers' growth performance trial, 
Józefiak et al. (2010) report that 0.1% BA supplementation significantly improved the growth 
performance during first two weeks growth, whereas, 0.2% BA supplementation significantly 
reduced the growth performance. Recently, Weber et al. (2012) conducted a meta-analysis of 
four growth trials and reports that supplementation of a blend of essential oils and benzoic 
acid at a dose of 300 mg/kg of feed significantly improved growth performance of broilers 
under different husbandry conditions. Contrary to the effects of BA in broilers, it is reported 
that much higher BA supplementation (1%) to piglets significantly improved body weights, 
feed intake and feed conversion efficiency (Kluge et al. 2006). The mechanism of different 
responses of BA in broilers and pigs is not known but it is hypothesized that it can be the 
result of difference in the metabolic pathway of BA in birds and mammals. In birds, BA is 
excreted by conjugation with ornithine (Nesheim and Garlich 1963), whereas, in mammals it 
is excreted in conjunction with glycine (Bridges et al. 1970). It is, therefore, expected that BA 
supplementation can result in arginine deficiency, (characterized by poor feathering) that is a 
source of ornithine in birds (Chu and Nesheim 1979). 
Metabolic activities and populations of gut microbiota have significant effects on the 
nutrients digestibility, bioavailability and therefore on overall host response and development 
(Rehman et al. 2008). These microbial attributes are influenced by number of variables like 
diet composition and type, dietary supplementations including prebiotics, probiotics, essential 
oils and organic acids (Klaenhammer 2000; Peñalver et al. 2005; Rehman et al. 2008; 
Goodarzi Boroojeni et al. 2014a). Microbial metabolites including lactic acid and short chain 
fatty acids are produced in response to anaerobic fermentation of different organic 
compounds (Cummings et al. 2001; Garcia et al. 2008) of exogenous or endogenous origins. 
For instance, lactic acid, acetic acid, propionic acid and butyric acid are produced from 
microbial fermentation of carbohydrates, whereas, i-butyric acid and i-valeric acid are 
produced from microbial fermentation of proteins, peptides and branched chain amino acids 
(Bourquin et al. 1993; Henningsson et al. 2002). Results of the current study depict that lactic 
acid production is modulated by both types of BA supplementation in the crop, gizzard and 
proximal small intestine, whereas, acetic acid and total short chain fatty acids are only 
increased in the gizzard by supplementation. Our findings are supported by the fact organic 
acids are rapidly degraded and absorbed in the upper segments of the gut leaving insufficient 
concentrations to reach the lower gut segments to induce desirable effects (Hume et al. 1993; 
Thompson and Hinton 1997; Van Immerseel et al. 2006; Goodarzi Boroojeni et al. 2014a). 
Contrary to these findings, Józefiak et al. (2010) reported that BA supplementation in broilers 
modulates the microbial metabolites in the lower segments of gut with no effect in the upper 
segments. Lactic acid and acetic acid are mainly produced by a group of bacteria termed as 
"lactic acid bacteria (LAB)" and includes Lactobacilli, Bidibobacteria, Enterococci, 
Bacteroides, Fusobacteria, Eubacteria, and Clostridia (Herich and Levkut 2002). The LAB, 
via production of lactic acid, modulates populations and proliferation of butyrate producing 
bacteria (Van Immerseel et al. 2006). Moreover, lactic acid itself acts a substrate for certain 
bacteria like propionibacteria that produce propionic acid and acetic acid by lactic acid 
metabolism (Macfarlane and Cummings 1997). Like other organic acids, lactic acid and 
acetic acid have antimicrobial actives in the un-dissociated form. Because of the lipophilic 
nature in un-dissociated forms, organic acids can rapidly diffuse across bacterial cell 
membranes (Dibner and Buttin 2002). Once inside the bacteria, they dissociate due to higher 
cytoplasmic pH leading to a reduction in cellular pH that will perturb the enzymatic reactions 
as well as nutrients transportation systems (Cherrington et al. 1991). Moreover, it also 
depletes the energy of bacterial cells, since to maintain pH homeostasis, protons have to be 
pumped out of the cell. This diversion of energy results in a bacteriostatic effect. The direct 
antimicrobial effect, after ingestion of organic acids, is of the highest magnitude in the 
foregut that includes the crop and gizzard (Dibner and Buttin 2002). The poultry crop, being 
the main colonization site for pathogens like E. coli and Salmonella, is a vital gut segment for 
the action of organic acids (Ewing and Cole 1994). In addition to the crop, the gizzard is 
another most important gut segment that harbors numerous lactic acid bacteria (Hinton et al. 
2000), especially Lactobacilli, and, therefore, can reduce the population of pathogenic 
bacteria (Engberg et al. 2004) by virtue of its acidic environment. Reduction in the pH of the 
gastrointestinal tract is thought to be another mechanism of action of organic acids (Van 
Immerseel et al. 2006), however, both the current and previous studies demonstrate that the 
pH of various segments of the gut remained unchanged after organic acid supplementation 
(Hume et al. 1993; Thompson and Hinton 1997; Józefiak et al. 2010; Goodarzi Boroojeni et 
al. 2014a). Our results demonstrate that FBA and SBA supplementation significantly reduced 
the production of i-butyric acid and i-valeric acid in the caecum, whereas, n-valeric acid in 
only reduced by SBA supplementation. It has been known that i-butyric acid and i-valeric 
acid are produced by bacterial fermentation of proteins, peptides as well as branched chain 
amino acids (Bourquin et al. 1993; Henningsson et al. 2002). Cardona et al. (2005) studied 
the relationship between faecal i-butyric acid and i-valeric acid in humans and different 
animal species including horses, pigs and rats, which demonstrate that both acids have 
significant correlation with each other irrespective of age, species, diet as well as husbandry 
conditions. This highlights that both acids are derived from endogenous protein, more 
specifically sloughed intestinal cells, reaching to the lower segment of gut. Based on these 
facts, it can be speculated that both types of BA might have reduced the sloughing of 
intestinal cells. 
 The microbial populations analysis in different segments of GIT of broilers 
supplemented with the FBA or the SBA indicates that Lactobacilli population is influenced in 
gizzard, proximal small intestine and ileum. Moreover, Enterococci are increased in proximal 
small intestine by both types of the BA supplementations, whereas, S. alactolyticus is only 
increased in ileum by the SBA supplementation. The other studied bacteria including E. coli, 
Bifidobacteria, Enterobacteria and different Clostridial clusters do not respond to dietary 
supplementation of different types of the BA. It has been observed that the feed entering in 
the crop is rich in readily fermentable carbohydrates. Lactobacilli have been shown to 
dominate the chicken crop and produce lactic acid from fermentable carbohydrates present in 
the feed. In our study, BA supplementation increased the production of lactic acid without 
affecting the population of Lactobacilli in crop. It seems that BA supplementation improved 
the fermentation potential of Lactobacilli without changing the bacterial concentration. Van 
Immerseel et al. (2006) reported that Lactobacilli stimulate the growth of butyric acid 
synthesizing bacteria by lactic acid production and, therefore, can reduce the Salmonella 
invasion (Van Immerseel et al. 2003). Moreover, Lactobacilli have also been shown to limit 
the growth of gut pathogens like C. perfringens (La Ragione et al. 2004; Kizerwetter-Swida 
and Binek 2005), E. coli (Jin et al. 1998) as well as Campylobacter (Stern et al. 2001) by 
competitive exclusion, antimicrobials production or immuno-modulation (Rolfe 2000; 
Koenen et al. 2004). Results of our study are in line with the findings of Józefiak et al. (2010) 
who reported that BA supplementation does not affect the LAB in crop, whereas, LAB 
increased in the ileum of broilers. However, contrary to our findings, Kluge et al. (2006) 
reported that supplementation of BA to piglets reduce the population of gram negative as well 
as LAB in stomach in dose dependent manner. This depicts that the action of BA depends 
upon the segment of GIT as well as animal species. In addition to Lactobacilli, Enterococci 
are also classified as LAB and have been shown to inhibit the growth of Salmonella in 
broilers (Kuritza et al. 2011). Moreover, E. faecium supplementation to pregnant gilts has 
been shown to modify the faecal microbial communities of gilts as well as their offspring 
which was characterized by an increase in the number of Lactobacilli (Starke et al. 2013). 
Czerwiński et al. (2010) reported that S. alactolyticus is a major LAB present in the caece of 
chickens. Results of our studies indicate that S. alactolyticus is major LAB in ileum as well as 
caecum. This bacterium was first isolated from the GIT of chicken and pig (Farrow et al. 
1984) and subsequently was also found in the GIT of duck and pigeon (Kurzak et al. 1998; 
Baele et al. 2002). To the best of our knowledge, this is the first observation that indicates the 
effect of BA supplementation on concentration of S. alactolyticus in the ileum of broilers.  
The results of microbial diversity indices indicate that evenness, Sorensen index and 
Renkonen index are modified by supplementation of FBA and SBA in ileum, whereas, no 
difference in the microbial diversity indices is observed in the caecum. The evenness is 
increased by FBA as well as SBA supplementation, whereas, the Sorensen index is increased 
by SBA supplementation only. Likewise, the Renkonen index indicates that microbial 
populations are dissimilar between CON and SBA groups. It is evident from the results of 
current study that SBA has more pronounced effects on gut microbial populations compared 
with the control group. For instance, SBA supplementation has increased the concentrations 
of total Lactobacilli, L. johnsoni, L. reutri and L. amylovorus in ileal digesta compared with 
the control group. These changes in the bacterial populations are the source of microbial 
diversity observed in ileal digesta after SBA supplementation. Oviedo-Rondon et al. (2010) 
reported that probiotics and essential oil plus benzoic acid mixture have pronounced effects 
on microbial ecology of ileum and caecum of broilers compared with the no supplemented 
groups. In conclusion, the observations of the current study depict that SBA has some 
advantages over FBA.   
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 Table 4.1. Response of different types of benzoic acid supplementation on body weights 
(g ± SE) of broilers 
Period Treatments 
CON FBA SBA 
1st Week 169.9 ± 6.8a 168.5 ± 3.2a 166.0 ± 9.2a 
2nd Week 468.0 ± 4.3a 466.3 ± 60.9a 430.7 ± 36.9b 
3rd Week 886.4 ± 77.6a 888.3 ± 64.3a 849.0 ± 74.3a 
4th Week 1471.3 ± 56.4a 1462.2 ± 67.4a 1403.5 ± 83.2a 
5th Week 2104.6 ± 93.0a 2105.1 ± 93.7a 2048.3 ± 112.1a 
Different superscriptsa-b in a column differed significantly (P < 0.05) 
 
Table 4.2. Response of different types of benzoic acid supplementation on feed intake (g 
± SE) of broilers 
Period Treatments 
CON FBA SBA 
1st Week 151.8 ± 14.1a 144.1 ± 2.6a 146.1 ± 11.8a 
2nd Week 518.4 ± 4.3a 477.8 ± 8.9ab 467.3 ± 14.5b 
3rd Week 1097.0 ± 34.5a 1030.4 ± 26.9a 1009.2 ± 27.6a 
4th Week 1876.6 ± 38.0a 1824.3 ± 33.1a 1778.8 ± 22.0a 
5th Week 2716.4 ± 195.0a 2660.7 ± 114.6a 2611.2 ± 74.7a 
Different superscriptsa-b in a column differed significantly (P < 0.05) 
 
Table 4.3. Response of different types of benzoic acid supplementation on feed 
conversion efficiency (ratio ± SE) of broilers 
Period Treatments 
CON FBA SBA 
1st Week 0.90 ± 0.07 0.86 ± 0.02 0.88 ± 0.06 
2nd Week 1.10 ± 0.01 1.00 ± 0.05 1.07 ± 0.02 
3rd Week 1.24 ± 0.04 1.16 ± 0.01 1.19 ± 0.02 
4th Week 1.28 ± 0.03 1.25 ± 0.02 1.27 ± 0.02 
5th Week 1.29 ± 0.02 1.26 ± 0.02 1.28 ± 0.02 
 
 
Table 4.4. Response of different types of benzoic acid supplementation on total short 
chain fatty acids (µM/g ± SE) in different organs of broilers  
Organs 
Treatments 
CON FBA SBA 
Crop 22.79 ± 2.47a 25.81 ± 2.57a 29.58 ± 2.33a 
Proventriculus 8.37 ± 2.08a 2.91 ± 0.68a 4.02 ± 1.50a 
Gizzard 1.05 ± 0.05b 1.95 ± 0.29a 1.99 ± 0.20a 
Proximal Intestine 1.76 ± 0.18a 1.91 ± 0.26a 1.94 ± 0.18a 
Ileum 7.90 ± 1.58a 6.52 ± 0.77a 5.83 ± 0.73a 
Caecum  146.33 ± 10.14a 132.44 ± 3.06a 126.11 ± 3.51a 
Different superscriptsa-b in a column differed significantly (P < 0.05)
 Table 4.5. Response of different types of benzoic acid supplementation on crop lactate 
and short chain fatty acids (µM/g ± SE) of broilers 
Metabolites Treatments 
CON FBA SBA 
L-Lactate 52.13 ± 3.55b 62.03 ± 4.01ab 64.90 ± 2.71a 
D-Lactate 38.69 ± 3.67b 61.73 ± 6.73a 72.25 ± 3.73a 
Acetic acid 22.61 ± 2.45a 25.54 ± 2.60a 29.03 ± 2.43a 
Propionic acid 0.13 ± 0.03a 0.20 ± 0.07a 0.44 ± 0.16a 
n-Butyric acid 0.04 ± 0.01a 0.04 ± 0.01a 0.05 ± 0.01a 
i-Valeric acid 0.02 ± 0.01b 0.02 ± 0.01b 0.03 ± 0.01a 
n-Valeric acid Not detected 0.02 0.05 ± 0.01 
Different superscriptsa-b in a column differed significantly (P < 0.05) 
Table 4.6. Response of different types of benzoic acid supplementation on 
proventriculus lactate and short chain fatty acids (µM/g ± SE) of broilers 
Metabolites Treatments 
CON FBA SBA 
L-Lactate 27.21 ± 6.28a 18.12 ± 8.11a 23.06 ± 8.37a 
D-Lactate 13.68 ± 3.86a 6.77 ± 1.96a 8.03 ± 5.77a 
Acetic acid 6.71 ± 1.71a 2.83 ± 0.66a 3.87 ± 1.50a 
Propionic acid 0.17 ± 0.05a 0.10 ± 0.06a 0.09 ± 0.01a 
n-Butyric acid 0.04 ± 0.01a 0.03 ± 0.01ab 0.02 ± 0.01b 
i-Valeric acid 0.023 ± 0.008a 0.014 ± 0.001a 0.022 ± 0.003a 
n-Valeric acid 0.032 0.07 0.021 ± 0.007 
Different superscriptsa-b in a column differed significantly (P < 0.05)
 Table 4.7. Response of different types of benzoic acid supplementation on gizzard 
lactate and short chain fatty acids (µM/g ± SE) of broilers 
Metabolites Treatments 
CON FBA SBA 
L-Lactate 2.60 ± 0.37b 5.13 ± 0.79a 5.90 ± 0.84a 
D-Lactate 2.65 ± 0.18b 5.56 ± 0.98a 6.14 ± 0.80a 
Acetic acid 0.99 ± 0.05b 1.89 ± 0.28a 1.93 ± 0.20a 
Propionic acid 0.02 ± 0.003a 0.03 ± 0.009a 0.03 ± 0.008a 
n-Butyric acid 0.018 ± 0.003a 0.014 ± 0.002b 0.019 ± 0.002a 
i-Valeric acid 0.009 ± 0.001a 0.011 ± 0.002a 0.007 ± 0.001a 
n-Valeric acid 0.014 ± 0.003 0.011 ± 0.001 Not detected 
Different superscriptsa-b in a column differed significantly (P < 0.05) 
 
Table 4.8. Response of different types of benzoic acid supplementation on proximal 
small intestine lactate and short chain fatty acids (µM/g ± SE) of broilers 
Metabolites Treatments 
CON FBA SBA 
L-Lactate 36.63 ± 2.81a 45.17 ± 6.83a 39.12 ± 4.37a 
D-Lactate 7.92 ± 1.23b 16.27 ± 2.60a 19.04 ± 2.19a 
Acetic acid 1.55 ± 0.16a 1.71 ± 0.25a 1.74 ± 0.17a 
Propionic acid 0.18 ± 0.05a 0.15 ± 0.03a 0.17 ± 0.02a 
n-Butyric acid 0.03 ± 0.005a 0.05 ± 0.004a 0.04 ± 0.003a 
Different superscriptsa-b in a column differed significantly (P < 0.05)
 Table 4.9. Response of different types of benzoic acid supplementation on ileum lactate 
and short chain fatty acids (µM/g ± SE) of broilers 
Metabolites Treatments 
CON FBA SBA 
L-Lactate 42.88 ± 7.78 58.26 ± 12.65 67.63 ± 8.72 
D-Lactate 23.64 ± 4.35 29.16 ± 6.70 35.86 ± 4.92 
Acetic acid 7.46 ± 1.46 6.25 ± 0.76 5.57 ± 0.70 
Propionic acid 0.21 ± 0.08 0.13 ± 0.01 0.12 ± 0.02 
n-Butyric acid 0.16 ± 0.06 0.10 ± 0.04 0.09 ± 0.05 
i-Valeric acid 0.03 ± 0.009 0.02 ± 0.002 0.02 ± 0.005 
n-Valeric acid 0.04 ± 0.003 0.03 ± 0.007 0.03 ± 0.006 
 
Table 4.10. Response of different types of benzoic acid supplementation on caecum 
short chain fatty acids (µM/g ± SE) of broilers 
Metabolites Treatments 
CON FBA SBA 
Acetic acid 102.47 ± 7.13a 93.94 ± 2.05a 88.67 ± 2.90a 
Propionic acid 16.76 ± 1.18a 15.01 ± 1.07a 14.77 ± 1.12a 
i-Butyric acid 1.55 ± 0.13a 1.13 ± 0.05b 1.01 ± 0.07b 
n-Butyric acid 21.23 ± 1.81a 19.27 ± 0.96a 18.90 ± 1.00a 
i-Valeric acid 2.06 ± 0.30a 1.32 ± 0.11b 1.16 ± 0.13b 
n-Valeric acid 2.24 ± 0.20a 1.78 ± 0.08ab 1.60 ± 0.06b 
Different superscriptsa-b in a column differed significantly (P < 0.05) 
 Different superscriptsa-b on bars differed significantly (P < 0.05) 
 
 
Different superscriptsa-b on bars differed significantly (P < 0.05)
  
 
 
 
 Table 4.11. Response of different types of benzoic acid supplementation on crop 
microbiota (Log10 bacterial cells/g ± SE) of broilers 
Microbiota 
(Log10) 
Treatments 
CON FBA SBA 
Lactobacilli spp. 10.79 ± 0.07 10.93 ± 0.06 10.92 ± 0.02 
E. coli/ Hafnia/ Shigella 5.36 ± 0.27 5.31 ± 0.18 4.96 ± 0.29 
Enterococci spp. 7.03 ± 0.05 7.10 ± 0.06 7.17 ± 0.04 
 
 
Table 4.12. Response of different types of benzoic acid supplementation on gizzard 
microbiota (Log10 bacterial cells/g ± SE) of broilers 
Microbiota 
(Log10) 
Treatments 
CON FBA SBA 
Lactobacilli spp. 9.47 ± 0.07b 9.71 ± 0.06a 9.70 ± 0.07a 
L. johnsoni 7.31 ± 0.19b 7.75 ± 0.07ab 8.01 ± 0.09a 
L. reuteri 6.94 ± 0.11b 7.25 ± 0.13ab 7.37 ± 0.07a 
L. amylovorus 6.55 ± 0.08a 6.79 ± 0.10a 6.79 ± 0.13a 
Different superscriptsa-b in a column differed significantly (P < 0.05) 
 Table 4.13. Response of different types of benzoic acid supplementation on proximal 
small intestine microbiota (Log10 bacterial cells/g ± SE) of broilers 
Microbiota 
(Log10) 
Treatments 
CON FBA SBA 
Lactobacilli spp.  9.23 ± 0.13b 9.80 ± 0.18a 9.76 ± 0.10a 
L. johnsoni 7.03 ± 0.28a 7.88 ± 0.26a 7.49 ±. 019a 
L. reuteri 6.59 ± 0.18b 7.23 ± 0.19a 7.72 ± 0.13a 
L. amylovorus 5.14 ± 0.10b 5.89 ± 0.23a 6.04 ± 0.16a 
Enterococci spp. 6.10 ± 0.12b 6.65 ± 0.14a 6.52 ± 0.10a 
Different superscriptsa-b in a column differed significantly (P < 0.05) 
 
Table 4.14. Response of different types of benzoic acid supplementation on ileal 
microbiota (Log10 bacterial cells/g ± SE) of broilers 
Microbiota 
(Log10) 
Treatments 
CON FBA SBA 
Lactobacilli spp. 8.88 ± 0.13b 9.56 ± 0.30ab 9.98 ± 0.21a 
L. johnsoni 5.88 ± 0.09c 6.70 ± 0.08b 7.26 ± 0.21a 
L. reuteri 6.25 ± 0.14b 7.00 ± 0.13a 7.17 ± 0.11a 
L. amylovorus 5.76 ± 0.13b 6.38 ± 0.30ab 6.99 ± 0.24a 
Bifidobacteria spp. 3.41 ± 0.14a 3.67 ± 0.27a 3.81 ± 0.19a 
E. coli/ Hafnia/ Shigella 6.16 ± 0.52a 5.62 ± 0.37a 5.43 ± 0.38a 
Enterococci spp. 7.73 ± 0.09a 7.55 ± 0.17a 7.43 ± 0.16a 
Enterobacteria spp. 6.07 ± 0.28a 5.47 ± 0.24a 5.29 ± 0.21a 
S. alactolyticus  9.20 ± 0.18b 10.18 ± 0.41ab 10.56 ± 0.25a 
Clostridial cluster I 6.84 ± 0.16a 7.03 ± 0.11a 6.75 ± 0.14a 
Clostridial cluster IV 7.33 ± 0.37a 7.33 ± 0.34a 6.88 ± 0.15a 
Clostridial cluster XIVa 8.27 ± 0.33a 8.28 ± 0.24a 7.92 ± 0.11a 
Different superscriptsa-c in a column differed significantly (P < 0.05) 
 
 
Table 4.15. Response of different types of benzoic acid supplementation on caecal 
microbiota (Log10 bacterial cells/g ± SE) of broilers 
Microbiota 
(Log10) 
Treatments 
CON FBA SBA 
Lactobacilli spp. 9.25 ± 0.05 9.19 ± 0.05 9.01 ± 0.12 
Bifidobacteria spp. 5.28 ± 0.04 5.33 ± 0.11 5.30 ± 0.08 
E. coli/ Hafnia/ Shigella 7.10 ± 0.15 6.77 ± 0.20 6.78 ± 0.11 
Enterococci spp. 6.99 ± 0.09 6.78 ± 0.08 6.98 ± 0.15 
Enterobacteria spp. 7.00 ± 0.05 7.06 ± 0.05 6.92 ± 0.05 
S. alactolyticus  11.29 ± 0.03 11.25 ± 0.03 11.20 ± 0.03 
Clostridial cluster I 6.86 ± 0.08 6.85 ± 0.11 6.99 ± 0.13 
Clostridial cluster IV 10.06 ± 0.01 10.13 ± 0.03 10.04 ± 0.01 
Clostridial cluster XIVa 11.00 ± 0.01 11.09 ± 0.05 11.07 ± 0.03 
 Table 4.16. Response of different types of benzoic acid supplementation on richness, 
evenness and microbial diversity indices in ileal digesta of broilers  
Parameters CON FBA SBA 
Richness 4.83 ± 0.75a 5.50 ± 1.12a 5.75 ± 0.41a 
Evenness 0.83 ± 0.04b 0.92 ± 0.01a 0.95 ± 0.01a 
Shannon Index 1.27 ± 0.18a 1.47 ± 0.23a 1.64 ± 0.07a 
Simpson Index 0.65 ± 0.08a 0.72 ± 0.07a 0.79 ± 0.02a 
Sorensen Index 0.59 ± 0.05b 0.55 ± 0.06b 0.88 ± 0.04a 
Different superscriptsa-b in a column differed significantly (P < 0.05) 
 
 
Table 4.17. Response of different types of benzoic acid supplementation on richness, 
evenness and microbial diversity indices in caecal digesta of broilers  
Parameters CON FBA SBA 
Richness 11.38 ± 0.50 11.75 ± 0.50 11.63 ± 0.32 
Evenness 0.95 ± 0.010 0.96 ± 0.003 0.96 ± 0.003 
Shannon Index 2.29 ± 0.04 2.37 ± 0.04 2.35 ± 0.03 
Simpson Index 0.90 ± 0.007 0.91 ± 0.004 0.90 ± 0.004 
Sorensen Index 0.89 ± 0.03 0.90 ± 0.05 0.93 ± 0.04 
 
 
 
 
 *on the bar indicated variation in the microbial ecology 
 
 
  
Figure 4.7. Dendrogram, based upon Sorensen index and unweighted pair-group 
method, demonstrating the similarity of banding patterns in the ileal digesta 
 
 
 
 Figure 4.8. Dendrogram, based upon Sorensen index and unweighted pair-group 
method, demonstrating the similarity of banding patterns in the caecal digesta 
 
CHAPTER 5 
SUMMARY 
 
Efficient poultry production depends upon a number of crucial factors that include 
optimum nutrient digestibility, bioavailability and maximum conversion into end products 
like meat and egg as well as low morbidity and mortality in the flock. In the past, antibiotics 
were used successfully as growth promoters in poultry and animal feed to improve 
production performance. However, it has become increasingly apparent that many problems 
are associated with the use of antibiotic growth promoters (AGPs); most importantly, the 
emergence of increasing numbers of microbes resistant to antibiotics. Therefore, AGPs were 
banned in the poultry as well as in the livestock industries of many countries. Due to 
withdrawal of AGPs, the poultry industry faced outbreak of diseases, high mortality, 
compromised growth performance and thus low profitability. Researchers and producers 
must, therefore, seek an alternate for AGPs that provide safety both for poultry and consumer 
health. Many potential candidates have subsequently been put forth and evaluated to replace 
AGPs that include prebiotics, probiotics, phytobiotics and organic acids. These AGPs 
replacers showed variable degree of success depending upon nutritional, managemental and 
hygienic conditions. Keeping in view the importance of AGP replacers, it was the purpose of 
this study to the growth promoting potential of β-galacto-oligosaccharides (β-GOS), a 
prebiotic, and benzoic acid (BA), an organic acid, in growing broilers. 
In experiment-1, 200 day old Hubbard broiler chicks, were randomly divided into four 
treatment groups (n = 50) with five replicates (n = 10) in each group. Birds in different 
treatment groups were allotted four different types of diets. Birds in the control group (β-
GOS-0) were given ad-libitum corn based basal diet, free of antimicrobials and coccidiostats, 
whereas birds in three other experimental groups were given the same basal diets 
supplemented with different concentrations of β-GOS i.e., 0.1% (β-GOS-1), 0.2% (β-GOS-
2) and 0.5% (β-GOS-5) for a period of 35 days. Birds in all the experimental groups were 
vaccinated against the Newcastle disease virus (NDV) and infectious bursal disease virus by 
giving primary and booster doses according to the schedule. Moreover, birds were also 
sensitized against 2, 4-dinitrochlorobenzene for determination of cell mediated immunity 
(CMI). Body weights, feed intake and feed conversion efficiency were determined on a 
weekly basis. At the end of experiment, ten birds from each group were slaughtered to collect 
blood, organs and caecal digesta for determination of serum biochemical metabolites and 
humoral immunity, organ characteristics and selected caecal digesta bacteria, respectively. 
Data were analyzed by using analysis of variance and incase of significant F-value (P < 0.05), 
data were subjected to Tukey's-HSD post hoc test. Results demonstrated that growth 
performance and feed conversion efficiency (FCE) of β-GOS supplemented birds were 
improved (P < 0.05) in a dose dependent manner, with the highest body weights (P < 0.05) 
and improved FCE (P < 0.05) observed in the β-GOS-5 group. Relative weights of liver and 
pancreas were higher (P < 0.05) in the β-GOS-1 group. Likewise, CMI was also higher (P < 
0.05) in the β-GOS-1 group. Concentrations of caecal Lactobacilli spp. were higher in the β-
GOS-2 and β-GOS-5 groups. The serum biochemical metabolites, humoral immunity in 
terms of antibodies titres against NDV and Clostridia spp. and coliforms were not affected by 
dietary supplementation of β-GOS. In conclusion, dietary supplementation of 0.5% β-GOS 
conferred a better response in terms of growth performance, feed conversion efficiency and 
caecal Lactobacilli spp. in broilers. 
In experiment-2, 120 day old male Cobb broiler chicks were randomly divided into 
three treatment groups (n = 40) with eight replicates (n = 5) in each group. Birds in different 
treatment groups were allotted three different types of diets. Birds in the control group 
(CON) were given ad-libitum maize based basal diets, free of antimicrobials and 
coccidiostats, whereas birds in two other experimental groups were given the same basal diets 
supplemented with two different types of BA i.e., 0.096% free BA (FBA) and 0.2% slow 
releasing BA (SBA) for a period of 35 days. Body weights, feed intake and feed conversion 
efficiency were determined on a weekly basis. At the end of the experimental period, birds 
from each group were slaughtered to collect digesta from the crop, proventriculus, gizzard, 
proximal small intestine, ileum and caecum for determination of benzoic acid, microbial 
metabolites, microbial populations and molecular microbial ecology. Data were analyzed by 
using analysis of variance and incase of significant F-value (P < 0.05), data were subjected to 
Tukey's-HSD post hoc test. Results revealed that overall growth performance, feed intake and 
FCE remained unchanged among all the treatment groups. Total short chain fatty acids were 
only increased (P < 0.05) in the gizzard by both types of BA supplementation. Likewise, D-
lactate concentration was increased (P < 0.05) by both types of BA in crop digesta, whereas, 
L-lactate was only increased (P < 0.05) by SBA in crop digesta. Both types of BA increased 
(P < 0.05) the concentrations of L-lactate, D-lactate and acetic acid in gizzard, and D-lactate 
in proximal small intestine. Concentrations of i-butyric acid and i-valeric acid were decreased 
(P < 0.05) in caecal digesta by both types of BA, whereas, n-valeric acid was only decreased 
(P < 0.05) by SBA supplementation in caecal digesta. Concentrations of both types of BA in 
different segments of gastrointestinal tract were comparable. Concentrations of gizzard 
Lactobacilli spp. were higher in both the BA supplemented groups, whereas, L. johnsoni and 
L. reuteri concentrations were higher in the SBA group compared with the control group. 
Similarly, in the proximal small intestine both types of BA increased the population of 
Lactobacilli spp., L. reuteri, L. amylovorus and Enterococci spp. Ileal concentrations of 
Lactobacilli spp., L. johnsoni, L. amylovorus and S. alactolyticus were higher (P < 0.05) in 
SBA group, whereas, L. reuteri was increased (P < 0.05) both by the FBA and SBA 
supplementations. Microbial populations of crop and caecum remained unchanged among all 
the treatment groups. Results of ileal molecular microbial ecology analysis revealed that 
evenness was higher (P < 0.05) in both the BA supplemented groups, whereas, the Sorensen 
index (P < 0.05) and the Renkonen index (< 0.5) were different only in the SBA group. 
However, caecal microbial ecology analysis revealed no changes among all the treatment 
groups. In conclusion, FBA and SBA supplementations produced similar responses in terms 
of microbial metabolites production with no effect on overall growth performance and feed 
conversion efficiency. However, SBA conferred some advantages over FBA in terms of 
increased bacterial concentrations, especially some species of the Lactobacilli as well as S. 
alactolyticus, and improved ileal molecular microbial ecology. 
 
